|
|
ý
|
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
For the Fiscal Year Ended December 31, 2016
|
|
|
Delaware
|
|
32-0436529
|
(State or other jurisdiction of
incorporation or organization)
|
|
(I.R.S. Employer
Identification No.)
|
|
Title of each class
|
|
Name of each exchange on which registered
|
Common units representing limited partner interests
|
|
New York Stock Exchange, Inc.
|
|
Large accelerated filer
¨
|
|
Accelerated filer
x
|
|
Non-accelerated filer
¨
|
|
Smaller reporting company
¨
|
|
|
|
|
(Do not check if a smaller
reporting company)
|
|
|
•
|
the amount of ethane that we are able to process, which could be adversely affected by, among other things, operating difficulties;
|
•
|
the volume of ethylene that we are able to sell;
|
•
|
the price at which we are able to sell ethylene;
|
•
|
industry market outlook, including prices and margins in third-party ethylene and co-products sales;
|
•
|
the parties to whom we will sell ethylene and on what basis;
|
•
|
volumes of ethylene that Westlake may purchase, in addition to the minimum commitment under the Ethylene Sales Agreement;
|
•
|
timing, funding and results of capital projects, such as OpCo's plan to increase the ethylene capacity of the ethylene production facility at Calvert City Olefins;
|
•
|
our intended minimum quarterly distributions and the manner of making such distributions;
|
•
|
our ability to meet our liquidity needs;
|
•
|
timing of and amount of capital expenditures;
|
•
|
potential loans from Westlake to OpCo to fund OpCo's expansion capital expenditures in the future;
|
•
|
expected mitigation of exposure to commodity price fluctuations;
|
•
|
turnaround activities and the variability of OpCo's cash flow;
|
•
|
compliance with present and future environmental regulations and costs associated with environmentally related penalties, capital expenditures, remedial actions and proceedings, including any new laws, regulations or treaties that may come into force to limit or control carbon dioxide and other greenhouse gas emissions or to address other issues of climate change; and
|
•
|
effects of pending legal proceedings.
|
•
|
general economic and business conditions;
|
•
|
the cyclical nature of the chemical industry;
|
•
|
the availability, cost and volatility of raw materials and energy;
|
•
|
uncertainties associated with the United States and worldwide economies, including those due to political tensions and unrest in the Middle East, the Commonwealth of Independent States (including Ukraine) and elsewhere;
|
•
|
current and potential governmental regulatory actions in the United States and regulatory actions and political unrest in other countries;
|
•
|
industry production capacity and operating rates;
|
•
|
the supply/demand balance for our product;
|
•
|
competitive products and pricing pressures;
|
•
|
instability in the credit and financial markets;
|
•
|
access to capital markets;
|
•
|
terrorist acts;
|
•
|
operating interruptions (including leaks, explosions, fires, weather-related incidents, mechanical failure, unscheduled downtime, labor difficulties, transportation interruptions, spills and releases and other environmental risks);
|
•
|
changes in laws or regulations;
|
•
|
technological developments;
|
•
|
our ability to integrate acquired businesses;
|
•
|
foreign currency exchange risks;
|
•
|
our ability to implement our business strategies; and
|
•
|
creditworthiness of our customers.
|
Public Common Units
|
47.8
|
%
|
|
Interests of Westlake:
|
|
|
|
Common Units
|
5.3
|
%
|
|
Subordinated Units
|
46.9
|
%
|
|
Non-Economic General Partner Interest
|
—
|
|
|
Incentive Distribution Rights
|
—
|
|
(1)
|
|
100.0
|
%
|
|
(1)
|
Incentive distribution rights represent a variable interest in distributions and thus are not expressed as a fixed percentage. Distributions with respect to the incentive distribution rights are classified as distributions with respect to equity interests.
|
•
|
two ethylene production facilities at Westlake's Lake Charles, Louisiana site ("Petro 1" and "Petro 2," collectively referred to as "Lake Charles Olefins"), with an annual combined capacity of approximately 3.0 billion pounds;
|
•
|
one ethylene production facility at Westlake's Calvert City, Kentucky site ("Calvert City Olefins"), with an annual capacity of approximately 630 million pounds; and
|
•
|
a 200-mile common carrier ethylene pipeline that runs from Mont Belvieu, Texas to the Longview, Texas chemical site, which includes Westlake's Longview PE production facility (the "Longview Pipeline").
|
Plant Location (Description)
|
|
Annual
Production
Capacity
(millions of
pounds)
|
|
Feedstock
|
|
Primary Uses of
Ethylene
|
||
Lake Charles, Louisiana (Petro 1)
|
|
|
1,500
|
|
|
Ethane
|
|
PE and PVC
|
Lake Charles, Louisiana (Petro 2)
|
|
|
1,490
|
|
|
Ethane, ethane/propane mix, propane,
butane or naphtha
|
|
PE and PVC
|
Calvert City, Kentucky (Calvert City Olefins)
|
|
|
630
|
|
|
Ethane or propane
|
|
PVC
|
Total
|
|
|
3,620
|
|
|
|
|
|
•
|
severe financial hardship or bankruptcy of Westlake or one of our other customers, or the occurrence of other events affecting our ability to collect payments from Westlake or our other customers, including any of our customers' default;
|
•
|
volatility and cyclical downturns in the chemicals industry and other industries which materially and adversely impact Westlake and our other customers;
|
•
|
Westlake's inability to perform, or any other default on its obligations, under the Ethylene Sales Agreement;
|
•
|
the age of, and changes in the reliability, efficiency and capacity of the various equipment and operating facilities used in OpCo's operations, and in the operations of Westlake and our other customers, business partners and/or suppliers;
|
•
|
the cost of environmental remediation at OpCo's facilities not covered by Westlake or third parties;
|
•
|
changes in the expected operating levels of OpCo's assets;
|
•
|
OpCo's ability to meet minimum volume requirements, yield standards and ethylene quality requirements in the Ethylene Sales Agreement;
|
•
|
OpCo's ability to renew the Ethylene Sales Agreement or to enter into new, long-term agreements for the sale of ethylene under terms similar or more favorable;
|
•
|
changes in the marketplace that may affect supply and demand for ethane or ethylene, including decreased availability of ethane (which may result from greater restrictions on hydraulic fracturing, any reduction in hydraulic fracturing due to low crude oil prices or exports of natural gas liquids from the United States, for example), increased production of ethylene or export of ethane or ethylene from the United States;
|
•
|
changes in overall levels of production, production capacity, pricing and/or margins for ethylene;
|
•
|
OpCo's ability to secure adequate supplies of ethane, other feedstocks and natural gas from Westlake or third parties;
|
•
|
the need to use higher priced or less attractive feedstock due to the unavailability of ethane;
|
•
|
the effects of pipeline, railroad, barge, truck and other transportation performance and costs, including any transportation disruptions;
|
•
|
the availability and cost of labor;
|
•
|
risks related to employees and workplace safety;
|
•
|
the effects of adverse events relating to the operation of OpCo's facilities and to the transportation and storage of hazardous materials (including equipment malfunction, explosions, fires, spills and the effects of severe weather conditions);
|
•
|
changes in product specifications for the ethylene that we produce;
|
•
|
changes in insurance markets and the level, types and costs of coverage available, and the financial ability of our insurers to meet their obligations;
|
•
|
changes in, or new, statutes, regulations or governmental policies by federal, state and local authorities with respect to protection of the environment;
|
•
|
changes in accounting rules and/or tax laws or their interpretations;
|
•
|
nonperformance or force majeure by, or disputes with or changes in contract terms with, Westlake, our other major customers, suppliers, dealers, distributors or other business partners; and
|
•
|
changes in, or new, statutes, regulations, governmental policies and taxes, or their interpretations.
|
•
|
the amount of cash we or OpCo are able to generate from sales of ethylene, and associated co-products, to third parties, which will be impacted by changes in prices for ethane (or other feedstocks), natural gas, ethylene and co-products and sustained lower prices of crude oil, such as those experienced since the third quarter of 2014 and continuing through 2016, and could be less than the margin we earn from ethylene sales to Westlake;
|
•
|
the level of capital expenditures we or OpCo make;
|
•
|
the cost of acquisitions;
|
•
|
construction costs;
|
•
|
fluctuations in our or OpCo's working capital needs;
|
•
|
our or OpCo's ability to borrow funds (including under our or OpCo's revolving credit facilities) and access capital markets;
|
•
|
our or OpCo's debt service requirements and other liabilities;
|
•
|
restrictions contained in our or OpCo's existing or future debt agreements; and
|
•
|
the amount of cash reserves established by our general partner.
|
•
|
make investments and other restricted payments;
|
•
|
incur additional indebtedness or issue preferred stock;
|
•
|
create liens;
|
•
|
sell all or substantially all of its assets or consolidate or merge with or into other companies; and
|
•
|
engage in transactions with affiliates.
|
•
|
mistaken assumptions about revenues and costs, including synergies;
|
•
|
the inability to successfully integrate the businesses we acquire;
|
•
|
the inability to hire, train or retain qualified personnel to manage and operate our business and newly acquired assets;
|
•
|
the assumption of unknown liabilities;
|
•
|
limitations on rights to indemnity from the seller;
|
•
|
mistaken assumptions about the overall costs of equity or debt;
|
•
|
the diversion of management's attention from other business concerns;
|
•
|
unforeseen difficulties in connection with operating in new product areas or new geographic areas; and
|
•
|
customer or key employee losses at the acquired businesses.
|
•
|
pipeline leaks and ruptures;
|
•
|
explosions;
|
•
|
fires;
|
•
|
severe weather and natural disasters;
|
•
|
mechanical failure;
|
•
|
unscheduled downtime;
|
•
|
labor difficulties;
|
•
|
transportation interruptions;
|
•
|
chemical spills;
|
•
|
discharges or releases of toxic or hazardous substances or gases;
|
•
|
storage tank leaks;
|
•
|
other environmental risks; and
|
•
|
terrorist attacks.
|
•
|
our general partner is allowed to take into account the interests of parties other than us, such as Westlake, in exercising certain rights under our partnership agreement;
|
•
|
neither our partnership agreement nor any other agreement requires Westlake to pursue a business strategy that favors us;
|
•
|
our partnership agreement replaces the fiduciary duties that would otherwise be owed by our general partner with contractual standards governing its duties, limits our general partner's liabilities and restricts the remedies available to our unitholders for actions that, without such limitations, might constitute breaches of fiduciary duty;
|
•
|
except in limited circumstances, our general partner has the power and authority to conduct our business without unitholder approval;
|
•
|
our general partner determines the amount and timing of asset purchases and sales, borrowings, issuances of additional partnership securities and the level of reserves, each of which can affect the amount of cash that is distributed to our unitholders;
|
•
|
our general partner determines the amount and timing of any cash expenditure and whether an expenditure is classified as a maintenance capital expenditure, which reduces operating surplus, or an expansion capital expenditure, which does not reduce operating surplus. This determination can affect the amount of cash from operating surplus that is distributed to our unitholders which, in turn, may affect the ability of the subordinated units to convert;
|
•
|
our general partner may cause us to borrow funds in order to permit the payment of cash distributions, even if the purpose or effect of the borrowing is to make a distribution on the subordinated units, to make incentive distributions or to accelerate the expiration of the subordination period, or may cause us not to borrow funds to pay cash distributions when we do not otherwise have the funds pay such cash distributions;
|
•
|
our partnership agreement permits us to distribute up to $28.0 million as operating surplus, even if it is generated from asset sales, non-working capital borrowings or other sources that would otherwise constitute capital surplus. This cash may be used to fund distributions on our subordinated units or the incentive distribution rights;
|
•
|
our general partner determines which costs incurred by it and its affiliates are reimbursable by us;
|
•
|
our partnership agreement does not restrict our general partner from causing us to pay it or its affiliates for any services rendered to us or entering into additional contractual arrangements with its affiliates on our behalf;
|
•
|
our general partner intends to limit its liability regarding our contractual and other obligations;
|
•
|
our general partner may exercise its right to call and purchase common units if it and its affiliates own more than 80% of the common units;
|
•
|
our general partner controls the enforcement of obligations that it and its affiliates owe to us;
|
•
|
our general partner decides whether to retain separate counsel, accountants or others to perform services for us; and
|
•
|
our general partner may elect to cause us to issue common units to it in connection with a resetting of the target distribution levels related to Westlake's incentive distribution rights without the approval of the conflicts committee of the board of directors or the unitholders. This election may result in lower distributions to the common unitholders in certain situations.
|
•
|
how to allocate business opportunities among us and its affiliates;
|
•
|
whether to exercise its call right;
|
•
|
how to exercise its voting rights with respect to the units it owns;
|
•
|
whether to exercise its registration rights;
|
•
|
whether to elect to reset target distribution levels; and
|
•
|
whether or not to consent to any merger or consolidation of the partnership or amendment to the partnership agreement.
|
•
|
whenever our general partner makes a determination or takes, or declines to take, any other action in its capacity as our general partner, our general partner is generally required to make such determination, or take or decline to take such other action, in good faith, and will not be subject to any higher standard imposed by our partnership agreement, Delaware law, or any other law, rule or regulation, or at equity;
|
•
|
our general partner and its officers and directors will not be liable for monetary damages or otherwise to us or our limited partners resulting from any act or omission unless there has been a final and non-appealable judgment entered by a court of competent jurisdiction determining that such losses or liabilities were the result of conduct in which our general partner or its officers or directors engaged in bad faith, meaning that they believed that the decision was adverse to the interest of the partnership or, with respect to any criminal conduct, with knowledge that such conduct was unlawful; and
|
•
|
our general partner will not be in breach of its obligations under the partnership agreement or its duties to us or our limited partners if a transaction with an affiliate or the resolution of a conflict of interest is:
|
(1)
|
approved by the conflicts committee of the board of directors, although our general partner is not obligated to seek such approval; or
|
(2)
|
approved by the vote of a majority of the outstanding common units, excluding any common units owned by our general partner and its affiliates.
|
•
|
our existing unitholders' proportionate ownership interest in us will decrease;
|
•
|
the amount of earnings per each unit may decrease;
|
•
|
because a lower percentage of total outstanding units will be subordinated units, the risk that a shortfall in the payment of the minimum quarterly distribution will be borne by our common unitholders will increase;
|
•
|
the ratio of taxable income to distributions may increase;
|
•
|
the relative voting strength of each previously outstanding unit may be diminished; and
|
•
|
the market price of the common units may decline.
|
|
|
High
|
|
Low
|
||||
Year Ended December 31, 2016
|
|
|
|
|
||||
4th Quarter
|
|
$
|
23.12
|
|
|
$
|
19.90
|
|
3rd Quarter
|
|
23.90
|
|
|
19.99
|
|
||
2nd Quarter
|
|
23.02
|
|
|
17.65
|
|
||
1st Quarter
|
|
22.08
|
|
|
16.39
|
|
||
Year Ended December 31, 2015
|
|
|
|
|
||||
4th Quarter
|
|
$
|
22.25
|
|
|
$
|
15.58
|
|
3rd Quarter
|
|
24.47
|
|
|
17.38
|
|
||
2nd Quarter
|
|
28.99
|
|
|
19.21
|
|
||
1st Quarter
|
|
27.82
|
|
|
24.95
|
|
Record Date
|
|
Payment Date
|
|
Amount per Limited Partner Unit
|
||
Year Ended December 31, 2016
|
|
|
|
|
||
February 7, 2017
|
|
February 22, 2017
|
|
$
|
0.3450
|
|
November 14, 2016
|
|
November 29, 2016
|
|
0.3353
|
|
|
August 9, 2016
|
|
August 23, 2016
|
|
0.3259
|
|
|
May 10, 2016
|
|
May 24, 2016
|
|
0.3168
|
|
|
Year Ended December 31, 2015
|
|
|
|
|
||
February 11, 2016
|
|
February 26, 2016
|
|
$
|
0.3080
|
|
November 9, 2015
|
|
November 27, 2015
|
|
0.2994
|
|
|
August 13, 2015
|
|
August 27, 2015
|
|
0.2910
|
|
|
May 12, 2015
|
|
May 27, 2015
|
|
0.2829
|
|
|
|
Year Ended December 31,
|
||||||||||||||||||
|
|
2016
|
|
2015
|
|
2014
(1)
|
|
2013
|
|
2012
|
||||||||||
|
|
|
|
|
|
|
|
Predecessor
|
|
Predecessor
|
||||||||||
|
|
(in thousands of dollars, except unit amounts and per unit data)
|
||||||||||||||||||
Statement of Operations Data:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Net sales
|
|
$
|
986,736
|
|
|
$
|
1,007,221
|
|
|
$
|
1,749,700
|
|
|
$
|
2,127,747
|
|
|
$
|
2,249,098
|
|
Gross profit
|
|
391,331
|
|
|
382,882
|
|
|
745,812
|
|
|
872,607
|
|
|
635,652
|
|
|||||
Selling, general and administrative expenses
|
|
24,887
|
|
|
23,550
|
|
|
29,256
|
|
|
25,451
|
|
|
24,103
|
|
|||||
Income from operations
|
|
366,444
|
|
|
359,332
|
|
|
716,556
|
|
|
847,156
|
|
|
611,549
|
|
|||||
Interest expense
|
|
(12,607
|
)
|
|
(4,967
|
)
|
|
(10,499
|
)
|
|
(8,032
|
)
|
|
(8,937
|
)
|
|||||
Other income, net
(2)
|
|
601
|
|
|
160
|
|
|
3,151
|
|
|
7,701
|
|
|
4,186
|
|
|||||
Income before income taxes
|
|
354,438
|
|
|
354,525
|
|
|
709,208
|
|
|
846,825
|
|
|
606,798
|
|
|||||
Provision for income taxes
|
|
1,035
|
|
|
672
|
|
|
199,388
|
|
|
300,279
|
|
|
210,878
|
|
|||||
Net income
|
|
$
|
353,403
|
|
|
$
|
353,853
|
|
|
$
|
509,820
|
|
|
$
|
546,546
|
|
|
$
|
395,920
|
|
Less: Predecessor net income prior to initial
public offering on August 4, 2014
|
|
—
|
|
|
—
|
|
|
361,334
|
|
|
|
|
|
|||||||
Net income subsequent to initial public
offering
|
|
353,403
|
|
|
353,853
|
|
|
148,486
|
|
|
|
|
|
|||||||
Less: Net income attributable to
noncontrolling interest in OpCo
|
|
312,463
|
|
|
314,022
|
|
|
134,909
|
|
|
|
|
|
|||||||
Net income attributable to Westlake
Chemical Partners LP subsequent to
initial public offering and limited
partners' interest in net income
|
|
$
|
40,940
|
|
|
$
|
39,831
|
|
|
$
|
13,577
|
|
|
|
|
|
||||
Net income attributable to
Westlake Chemical Partners LP
subsequent to initial public offering
per limited partner unit (basic and
diluted)
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Common units
|
|
$
|
1.50
|
|
|
$
|
1.47
|
|
|
$
|
0.50
|
|
|
|
|
|
||||
Subordinated units
|
|
$
|
1.50
|
|
|
$
|
1.47
|
|
|
$
|
0.50
|
|
|
|
|
|
||||
Balance Sheet Data (end of period):
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Cash and cash equivalents
|
|
$
|
88,900
|
|
|
$
|
169,559
|
|
|
$
|
133,750
|
|
|
$
|
—
|
|
|
$
|
—
|
|
Working capital
(3)
|
|
194,388
|
|
|
167,593
|
|
|
164,661
|
|
|
43,642
|
|
|
40,336
|
|
|||||
Total assets
|
|
1,555,228
|
|
|
1,290,349
|
|
|
1,096,435
|
|
|
1,041,474
|
|
|
834,843
|
|
|||||
Total debt
|
|
594,629
|
|
|
384,006
|
|
|
227,638
|
|
|
252,973
|
|
|
253,000
|
|
|||||
Partners' equity
|
|
920,963
|
|
|
847,167
|
|
|
834,950
|
|
|
455,432
|
|
|
273,812
|
|
|||||
Distributions per unit
(4)
|
|
$
|
1.32
|
|
|
$
|
1.18
|
|
|
$
|
0.45
|
|
|
$
|
—
|
|
|
$
|
—
|
|
Other Operating Data:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Cash flow from:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Operating activities
|
|
$
|
287,726
|
|
|
$
|
452,542
|
|
|
$
|
604,012
|
|
|
$
|
602,509
|
|
|
$
|
496,821
|
|
Investing activities
|
|
(299,481
|
)
|
|
(231,185
|
)
|
|
(202,956
|
)
|
|
(230,050
|
)
|
|
(158,008
|
)
|
|||||
Financing activities
|
|
(68,904
|
)
|
|
(185,548
|
)
|
|
(267,306
|
)
|
|
(372,459
|
)
|
|
(338,813
|
)
|
|||||
Depreciation and amortization
|
|
98,210
|
|
|
81,210
|
|
|
77,611
|
|
|
73,463
|
|
|
64,257
|
|
|||||
Capital expenditures
|
|
299,638
|
|
|
231,185
|
|
|
202,823
|
|
|
223,130
|
|
|
158,440
|
|
|||||
MLP distributable cash flow
(5)
|
|
32,405
|
|
|
37,730
|
|
|
13,812
|
|
|
—
|
|
|
—
|
|
|||||
EBITDA
(6)
|
|
$
|
465,255
|
|
|
$
|
440,702
|
|
|
$
|
797,318
|
|
|
$
|
928,320
|
|
|
$
|
679,992
|
|
(1)
|
Includes amounts for the pre-IPO period from January 1, 2014 through August 3, 2014 and post-IPO period from August 4, 2014 through December 31, 2014.
|
(2)
|
Pre-IPO 2014 and 2013 Predecessor's other income, net are composed of equity in income of joint venture, claims recovery, franchise taxes and other gains and losses.
|
(3)
|
Working capital equals current assets less current liabilities.
|
(4)
|
Distribution per unit for 2014 represents cash distributions per common and subordinated units for the initial period from August 4, 2014 to September 30, 2014 and for the quarter ended December 31, 2014. Distribution per unit for 2016 and 2015 represents cash distributions per common and subordinated units for the quarters ended March 31, June 30, September 30 and December 31.
|
(5)
|
We also use MLP distributable cash flow (a non-GAAP financial measure) to analyze our performance. We define distributable cash flow as net income plus depreciation and amortization, less contributions for turnaround reserves and maintenance capital expenditures. We define MLP distributable cash flow as distributable cash flow attributable to periods subsequent to the date of our IPO less distributable cash flow attributable to Westlake's noncontrolling interest in OpCo. MLP distributable cash flow does not reflect changes in working capital balances. MLP distributable cash flow is a non-GAAP supplemental financial measure that management and external users of our consolidated financial statements, such as industry analysts, investors, lenders and rating agencies, may use to assess our operating performance as compared to other publicly traded partnerships, our ability to incur and service debt and fund capital expenditures and the viability of acquisitions and other capital expenditure projects and the returns on investment of various investment opportunities. We believe that the presentation of MLP distributable cash flow provides useful information to investors in assessing our financial condition and results of operations. MLP distributable cash flow should not be considered an alternative to GAAP net income or net cash provided by operating activities. MLP distributable cash flow has important limitations as an analytical tool because it excludes some but not all items that affect net income and net cash provided by operating activities. MLP distributable cash flow should not be considered in isolation or as a substitute for analysis of our results as reported under GAAP. It should be noted that other limited partnerships and companies calculate MLP distributable cash flows differently, and, therefore, MLP distributable cash flows as presented for us may not be comparable to MLP distributable cash flows reported by other partnerships and companies. The following table reconciles MLP distributable cash flow to net income and net cash provided by operating activities, the most directly comparable GAAP financial measures.
|
|
|
Year Ended December 31,
|
||||||||||
|
|
2016
|
|
2015
|
|
2014
|
||||||
Net cash provided by operating activities
|
|
$
|
287,726
|
|
|
$
|
452,542
|
|
|
$
|
604,012
|
|
Provision for doubtful accounts
|
|
(394
|
)
|
|
(170
|
)
|
|
(65
|
)
|
|||
Loss from disposition of fixed assets
|
|
(3,021
|
)
|
|
(1,812
|
)
|
|
(1,544
|
)
|
|||
Deferred income taxes
|
|
(344
|
)
|
|
456
|
|
|
(8,608
|
)
|
|||
Income from equity method investment, net of dividend
|
|
—
|
|
|
—
|
|
|
(1,073
|
)
|
|||
Changes in operating assets and liabilities and other
|
|
69,436
|
|
|
(97,163
|
)
|
|
(82,902
|
)
|
|||
Net Income
|
|
$
|
353,403
|
|
|
$
|
353,853
|
|
|
$
|
509,820
|
|
Add:
|
|
|
|
|
|
|
||||||
Depreciation and amortization
(1) (3)
|
|
98,210
|
|
|
81,210
|
|
|
31,831
|
|
|||
Less:
|
|
|
|
|
|
|
||||||
Contribution to turnaround reserves
(1)
|
|
40,014
|
|
|
28,183
|
|
|
11,947
|
|
|||
Maintenance capital expenditures
(1) (2)
|
|
120,353
|
|
|
67,935
|
|
|
17,629
|
|
|||
Net income attributable to the Predecessor
|
|
—
|
|
|
—
|
|
|
361,334
|
|
|||
Incentive distribution rights
|
|
281
|
|
|
—
|
|
|
—
|
|
|||
Distributable cash flow attributable to noncontrolling
interest in OpCo
|
|
258,560
|
|
|
301,215
|
|
|
136,929
|
|
|||
MLP distributable cash flow
|
|
$
|
32,405
|
|
|
$
|
37,730
|
|
|
$
|
13,812
|
|
(6)
|
EBITDA (a non-GAAP financial measure) is calculated as net income before interest expense, income taxes, depreciation and amortization. The body of accounting principles generally accepted in the United States is commonly referred to as "GAAP." For this purpose a non-GAAP financial measure is generally defined by the SEC as one that purports to measure historical and future financial performance, financial position or cash flows, but excludes or includes amounts that would not be so adjusted in the most comparable GAAP measures. We have included EBITDA in this Form 10-K because, in addition to the MLP distributable cash flow measure as described above, our management considers EBITDA an important supplemental measure of our performance and believes that it is frequently used by securities analysts, investors and other interested parties in the evaluation of partnerships and companies in our industry, some of which present EBITDA when reporting their results. We regularly evaluate our performance as compared to other partnerships and companies in our industry that have different financing and capital structures and/or tax rates by using EBITDA. EBITDA allows for meaningful performance comparisons by adjusting for factors such as interest expense, depreciation and amortization and taxes, which often vary from company to company. In addition, we utilize EBITDA in evaluating acquisition targets. Management also believes that EBITDA is a useful tool for measuring our ability to meet our future debt service, capital expenditures and working capital requirements, and EBITDA is commonly used by us and our investors to measure our ability to service indebtedness. EBITDA is not a substitute for the GAAP measures of earnings or of cash flow and is not necessarily a measure of our ability to fund our cash needs. In addition, it should be noted that companies calculate EBITDA differently and, therefore, EBITDA as presented in this Form 10-K may not be comparable to EBITDA reported by other companies. EBITDA has material limitations as an analytical tool because it excludes (1) interest expense, which is a necessary element of our costs and ability to generate revenues because we have borrowed money to finance our operations, (2) depreciation, which is a necessary element of our costs and ability to generate revenues because we use capital assets and (3) income taxes, which was a necessary element of Predecessor's operations. We compensate for these limitations by relying primarily on our GAAP results and using EBITDA only supplementally. The following table reconciles EBITDA to net income and to cash flows from operating activities, the most directly comparable GAAP measures.
|
|
|
Year Ended December 31,
|
||||||||||||||||||
|
|
2016
|
|
2015
|
|
2014
|
|
2013
|
|
2012
|
||||||||||
|
|
|
|
|
|
|
|
Predecessor
|
|
Predecessor
|
||||||||||
Net cash provided by operating
activities
|
|
$
|
287,726
|
|
|
$
|
452,542
|
|
|
$
|
604,012
|
|
|
$
|
602,509
|
|
|
$
|
496,821
|
|
Provision for doubtful accounts
|
|
(394
|
)
|
|
(170
|
)
|
|
(65
|
)
|
|
(40
|
)
|
|
(82
|
)
|
|||||
Loss from disposition of fixed
assets
|
|
(3,021
|
)
|
|
(1,812
|
)
|
|
(1,544
|
)
|
|
(1,905
|
)
|
|
(2,834
|
)
|
|||||
Deferred income taxes
|
|
(344
|
)
|
|
456
|
|
|
(8,608
|
)
|
|
(37,054
|
)
|
|
8,096
|
|
|||||
Income from equity method
investment, net of dividend
|
|
—
|
|
|
—
|
|
|
(1,073
|
)
|
|
(402
|
)
|
|
(277
|
)
|
|||||
Changes in operating assets and
liabilities and other
|
|
69,436
|
|
|
(97,163
|
)
|
|
(82,902
|
)
|
|
(16,562
|
)
|
|
(105,804
|
)
|
|||||
Net income
|
|
$
|
353,403
|
|
|
$
|
353,853
|
|
|
$
|
509,820
|
|
|
$
|
546,546
|
|
|
$
|
395,920
|
|
Add:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Depreciation and amortization
|
|
98,210
|
|
|
81,210
|
|
|
77,611
|
|
|
73,463
|
|
|
64,257
|
|
|||||
Interest expense
|
|
12,607
|
|
|
4,967
|
|
|
10,499
|
|
|
8,032
|
|
|
8,937
|
|
|||||
Provision for income taxes
|
|
1,035
|
|
|
672
|
|
|
199,388
|
|
|
300,279
|
|
|
210,878
|
|
|||||
EBITDA
|
|
$
|
465,255
|
|
|
$
|
440,702
|
|
|
$
|
797,318
|
|
|
$
|
928,320
|
|
|
$
|
679,992
|
|
•
|
produce sufficient volumes of ethylene to meet our commitments under the Ethylene Sales Agreement or recover our estimated costs through the pricing provisions of the Ethylene Sales Agreement;
|
•
|
contract with third parties for the remaining uncommitted production capacity;
|
•
|
add or increase capacity at our existing production facilities, or add additional production capacity via organic expansion projects and acquisitions; and
|
•
|
achieve or exceed the specified yield factors for natural gas, ethane and other feedstock under the Ethylene Sales Agreement.
|
•
|
our operating performance as compared to other publicly traded partnerships;
|
•
|
our ability to incur and service debt and fund capital expenditures;
|
•
|
the viability of acquisitions and other capital expenditure projects and the returns on investment of various investment opportunities.
|
|
|
Year Ended December 31,
|
||||||||||
|
|
2016
|
|
2015
|
|
2014
|
||||||
|
|
|
|
|
|
|
||||||
|
|
(in thousands of dollars, except unit amounts and per unit data)
|
||||||||||
Net sales—Westlake
|
|
$
|
853,719
|
|
|
$
|
834,918
|
|
|
$
|
1,292,089
|
|
Net co-products, ethylene and feedstock sales—third parties
|
|
133,017
|
|
|
172,303
|
|
|
457,611
|
|
|||
Total net sales
|
|
986,736
|
|
|
1,007,221
|
|
|
1,749,700
|
|
|||
Gross profit
|
|
391,331
|
|
|
382,882
|
|
|
745,812
|
|
|||
Selling, general and administrative expenses
|
|
24,887
|
|
|
23,550
|
|
|
29,256
|
|
|||
Income from operations
|
|
366,444
|
|
|
359,332
|
|
|
716,556
|
|
|||
Other income (expense)
|
|
|
|
|
|
|
||||||
Interest expense—Westlake
|
|
(12,607
|
)
|
|
(4,967
|
)
|
|
(10,499
|
)
|
|||
Other income, net
|
|
601
|
|
|
160
|
|
|
3,151
|
|
|||
Income before income taxes
|
|
354,438
|
|
|
354,525
|
|
|
709,208
|
|
|||
Provision for income taxes
|
|
1,035
|
|
|
672
|
|
|
199,388
|
|
|||
Net income
|
|
$
|
353,403
|
|
|
$
|
353,853
|
|
|
$
|
509,820
|
|
Less: Predecessor net income prior to initial public
offering on August 4, 2014 |
|
—
|
|
|
—
|
|
|
361,334
|
|
|||
Net income subsequent to initial public offering
|
|
353,403
|
|
|
353,853
|
|
|
148,486
|
|
|||
Less: Net income attributable to noncontrolling
interest in OpCo |
|
312,463
|
|
|
314,022
|
|
|
134,909
|
|
|||
Net income attributable to Westlake Chemical
Partners LP subsequent to initial public offering and limited partners' interest in net income |
|
$
|
40,940
|
|
|
$
|
39,831
|
|
|
$
|
13,577
|
|
Net income attributable to Westlake Chemical
Partners LP subsequent to initial public offering per limited partner unit (basic and diluted) |
|
|
|
|
|
|
||||||
Common units
|
|
$
|
1.50
|
|
|
$
|
1.47
|
|
|
$
|
0.50
|
|
Subordinated units
|
|
$
|
1.50
|
|
|
$
|
1.47
|
|
|
$
|
0.50
|
|
Weighted average limited partner units outstanding
(basic and diluted) |
|
|
|
|
|
|
||||||
Common units—public
|
|
12,937,500
|
|
|
12,937,500
|
|
|
12,937,500
|
|
|||
Common units—Westlake
|
|
1,436,115
|
|
|
1,436,115
|
|
|
1,436,115
|
|
|||
Subordinated units—Westlake
|
|
12,686,115
|
|
|
12,686,115
|
|
|
12,686,115
|
|
|
|
Year Ended December 31,
|
||||||||||
|
|
2016
|
|
2015
|
||||||||
|
|
Average Sales
Price |
|
Volume
|
|
Average Sales
Price
|
|
Volume
|
||||
Product sales price and volume percentage change
from prior year
|
|
+10.1
|
%
|
|
-12.1
|
%
|
|
-38.0
|
%
|
|
-4.4
|
%
|
|
|
Year Ended December 31,
|
|||||||
|
|
2016
|
|
2015
|
|
2014
|
|||
Average industry prices
(1)
|
|
|
|
|
|
|
|||
Ethane (cents/lb)
|
|
6.6
|
|
|
6.2
|
|
|
9.0
|
|
Propane (cents/lb)
|
|
11.4
|
|
|
10.7
|
|
|
24.7
|
|
Ethylene (cents/lb)
(2)
|
|
26.9
|
|
|
30.6
|
|
|
58.4
|
|
(1)
|
Industry pricing data was obtained through IHS Chemical. We have not independently verified the data.
|
(2)
|
Represents average North American spot prices of ethylene over the period as reported by IHS Chemical.
|
|
|
Payment Due by Period
|
||||||||||||||||||
|
|
Total
|
|
2017
|
|
2018-2019
|
|
2020-2021
|
|
Thereafter
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
|
(dollars in millions)
|
||||||||||||||||||
Contractual Obligations
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Total Debt:
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
Principal
(1)
|
|
$
|
594.7
|
|
|
$
|
—
|
|
|
$
|
562.9
|
|
|
$
|
—
|
|
|
$
|
31.8
|
|
Interest
(2)
|
|
58.6
|
|
|
22.8
|
|
|
30.1
|
|
|
3.3
|
|
|
2.4
|
|
|||||
Operating leases
(3)
|
|
4.6
|
|
|
1.1
|
|
|
1.7
|
|
|
1.4
|
|
|
0.4
|
|
|||||
Purchase obligations
(4)
|
|
31.1
|
|
|
31.1
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
Total
|
|
$
|
689.0
|
|
|
$
|
55.0
|
|
|
$
|
594.7
|
|
|
$
|
4.7
|
|
|
$
|
34.6
|
|
(1)
|
Long-Term Debt
. Long-term debt consists of the August 2013 Promissory Notes and the revolving credit facilities.
|
(2)
|
Interest Payments.
Interest payments are based on interest rates in effect at
December 31, 2016
and assume contractual amortization payments.
|
(3)
|
Operating Leases.
Represent noncancelable operating leases with respect to rail cars that are subleased to OpCo and two site lease agreements for various periods. Pursuant to the site lease agreements, OpCo leases the real property underlying Lake Charles Olefins and Calvert City Olefins. OpCo is also granted rights to access and use certain other portions of Westlake's production facilities that are necessary to operate OpCo's ethylene production facilities. OpCo owes Westlake one dollar per site per year. Each of the site lease agreements has a term of 50 years.
|
(4)
|
Purchase Obligations.
Purchase obligations include agreements to purchase goods and services that are enforceable and legally binding and that specify all significant terms, including a minimum quantity and price. We are party to various obligations to purchase goods and services, including the Services and Secondment Agreement, in the ordinary course of our business, as well as various purchase commitments for our capital projects.
|
|
Page
|
|
|
Management's Report on Internal Control over Financial Reporting
|
|
Consolidated and Combined F
inancial Statements:
|
|
Consolidated Balance Sheets as of December 31, 2016 and 2015
|
|
Consolidated and Combined Statements of Operations for the Years Ended December 31, 2016, 2015 and
2014
|
|
Consolidated Statement of Comprehensive Income for the Years Ended December 31, 2016 and 2015
|
|
Consolidated and Combined Statements of Changes in Equity
for the Years Ended
December 31, 2016, 2015
and 2014
|
|
Consolidated and Combined
Statements of Cash Flows for the Years Ended
December 31, 2016, 2015 and
2014
|
|
Notes to Consolidated and Combined Financial Statements
|
|
|
December 31,
2016 |
|
December 31,
2015 |
||||
|
|
|
|
|
||||
|
|
(in thousands of dollars,
except unit amounts)
|
||||||
ASSETS
|
|
|
|
|
||||
Current assets
|
|
|
|
|
||||
Cash and cash equivalents
|
|
$
|
88,900
|
|
|
$
|
169,559
|
|
Accounts receivable, net—Westlake Chemical Corporation ("Westlake")
|
|
126,977
|
|
|
39,655
|
|
||
Accounts receivable, net—third parties
|
|
12,085
|
|
|
11,927
|
|
||
Inventories
|
|
3,934
|
|
|
3,879
|
|
||
Prepaid expenses and other current assets
|
|
269
|
|
|
267
|
|
||
Total current assets
|
|
232,165
|
|
|
225,287
|
|
||
Property, plant and equipment, net
|
|
1,222,238
|
|
|
1,020,469
|
|
||
Other assets, net
|
|
|
|
|
||||
Goodwill
|
|
5,814
|
|
|
5,814
|
|
||
Deferred charges and other assets, net
|
|
95,011
|
|
|
38,779
|
|
||
Total other assets, net
|
|
100,825
|
|
|
44,593
|
|
||
Total assets
|
|
$
|
1,555,228
|
|
|
$
|
1,290,349
|
|
LIABILITIES
|
|
|
|
|
||||
Current liabilities
|
|
|
|
|
||||
Accounts payable—Westlake
|
|
$
|
12,130
|
|
|
$
|
15,550
|
|
Accounts payable—third parties
|
|
9,930
|
|
|
18,737
|
|
||
Accrued liabilities
|
|
15,717
|
|
|
23,407
|
|
||
Total current liabilities
|
|
37,777
|
|
|
57,694
|
|
||
Long-term debt payable to Westlake
|
|
594,629
|
|
|
384,006
|
|
||
Deferred income taxes
|
|
1,736
|
|
|
1,392
|
|
||
Other liabilities
|
|
123
|
|
|
90
|
|
||
Total liabilities
|
|
634,265
|
|
|
443,182
|
|
||
Commitments and contingencies (Notes 8 and 18)
|
|
|
|
|
|
|
||
EQUITY
|
|
|
|
|
||||
Common unitholders—public (12,937,500 units issued and outstanding)
|
|
297,367
|
|
|
294,565
|
|
||
Common unitholder—Westlake (1,436,115 units issued and outstanding)
|
|
4,813
|
|
|
4,502
|
|
||
Subordinated unitholder—Westlake (12,686,115 units issued and outstanding)
|
|
42,534
|
|
|
39,786
|
|
||
General partner—Westlake
|
|
(242,430
|
)
|
|
(242,572
|
)
|
||
Accumulated other comprehensive income
|
|
200
|
|
|
280
|
|
||
Total Westlake Chemical Partners LP partners' capital
|
|
102,484
|
|
|
96,561
|
|
||
Noncontrolling interest in Westlake Chemical OpCo LP ("OpCo")
|
|
818,479
|
|
|
750,606
|
|
||
Total equity
|
|
920,963
|
|
|
847,167
|
|
||
Total liabilities and equity
|
|
$
|
1,555,228
|
|
|
$
|
1,290,349
|
|
|
|
Year Ended December 31,
|
||||||||||
|
|
2016
|
|
2015
|
|
2014
|
||||||
|
|
|
|
|
|
|
||||||
|
|
(in thousands of dollars,
except unit amounts and per unit data)
|
||||||||||
Revenue
|
|
|
|
|
|
|
||||||
Net sales—Westlake
|
|
$
|
853,719
|
|
|
$
|
834,918
|
|
|
$
|
1,292,089
|
|
Net co-products, ethylene and feedstock sales—third parties
|
|
133,017
|
|
|
172,303
|
|
|
457,611
|
|
|||
Total net sales
|
|
986,736
|
|
|
1,007,221
|
|
|
1,749,700
|
|
|||
Cost of sales
|
|
595,405
|
|
|
624,339
|
|
|
1,003,888
|
|
|||
Gross profit
|
|
391,331
|
|
|
382,882
|
|
|
745,812
|
|
|||
Selling, general and administrative expenses
|
|
24,887
|
|
|
23,550
|
|
|
29,256
|
|
|||
Income from operations
|
|
366,444
|
|
|
359,332
|
|
|
716,556
|
|
|||
Other income (expense)
|
|
|
|
|
|
|
||||||
Interest expense—Westlake
|
|
(12,607
|
)
|
|
(4,967
|
)
|
|
(10,499
|
)
|
|||
Other income, net
|
|
601
|
|
|
160
|
|
|
3,151
|
|
|||
Income before income taxes
|
|
354,438
|
|
|
354,525
|
|
|
709,208
|
|
|||
Provision for income taxes
|
|
1,035
|
|
|
672
|
|
|
199,388
|
|
|||
Net income
|
|
$
|
353,403
|
|
|
$
|
353,853
|
|
|
$
|
509,820
|
|
Less: Predecessor net income prior to initial public offering on
August 4, 2014
|
|
—
|
|
|
—
|
|
|
361,334
|
|
|||
Net income subsequent to initial public offering
|
|
353,403
|
|
|
353,853
|
|
|
148,486
|
|
|||
Less: Net income attributable to noncontrolling interest in OpCo
|
|
312,463
|
|
|
314,022
|
|
|
134,909
|
|
|||
Net income attributable to Westlake Chemical Partners LP subsequent
to initial public offering and limited partners' interest in net income
|
|
$
|
40,940
|
|
|
$
|
39,831
|
|
|
$
|
13,577
|
|
Net income attributable to Westlake Chemical Partners LP subsequent
to initial public offering per limited partner unit (basic and diluted)
|
|
|
|
|
|
|
||||||
Common units
|
|
$
|
1.50
|
|
|
$
|
1.47
|
|
|
$
|
0.50
|
|
Subordinated units
|
|
$
|
1.50
|
|
|
$
|
1.47
|
|
|
$
|
0.50
|
|
Weighted average limited partner units outstanding
(basic and diluted)
|
|
|
|
|
|
|
||||||
Common units—public
|
|
12,937,500
|
|
|
12,937,500
|
|
|
12,937,500
|
|
|||
Common units—Westlake
|
|
1,436,115
|
|
|
1,436,115
|
|
|
1,436,115
|
|
|||
Subordinated units—Westlake
|
|
12,686,115
|
|
|
12,686,115
|
|
|
12,686,115
|
|
|||
Distributions per common unit
|
|
$
|
1.29
|
|
|
$
|
1.15
|
|
|
$
|
0.45
|
|
|
|
Year Ended December 31
|
||||||
|
|
2016
|
|
2015
|
||||
|
|
|
|
|
||||
|
|
(in thousands of dollars)
|
||||||
Net income
|
|
$
|
353,403
|
|
|
$
|
353,853
|
|
Other comprehensive income:
|
|
|
|
|
||||
Cash flow hedge:
|
|
|
|
|
||||
Interest rate contract:
|
|
|
|
|
||||
Adjustments in fair value of cash flow hedge
|
|
(416
|
)
|
|
85
|
|
||
Reclassification of losses to net income
|
|
336
|
|
|
195
|
|
||
Total other comprehensive income
|
|
(80
|
)
|
|
280
|
|
||
Comprehensive income
|
|
353,323
|
|
|
354,133
|
|
||
Comprehensive income attributable to noncontrolling interest in OpCo
|
|
312,463
|
|
|
314,022
|
|
||
Comprehensive income attributable to Westlake Chemical Partners LP
|
|
$
|
40,860
|
|
|
$
|
40,111
|
|
|
|
Predecessor
|
|
Partnership
|
||||||||||||||||||||||||||||
|
|
Net
Investment
|
|
Common Unitholders -
Public
|
|
Common Unitholder -
Westlake
|
|
Subordinated Unitholder -
Westlake
|
|
General
Partner -
Westlake
|
|
Accumulated
Other
Comprehensive
Income
|
|
Noncontrolling Interest
in OpCo
|
|
Total
|
||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
|
|
(in thousands of dollars)
|
||||||||||||||||||||||||||||||
Balances at December 31, 2013
|
|
$
|
455,432
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
455,432
|
|
Net income from January 1, 2014
through August 3, 2014
|
|
361,334
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
361,334
|
|
||||||||
Net distributions to Westlake prior to
initial public offering
|
|
(448,101
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(448,101
|
)
|
||||||||
Predecessor net liabilities not assumed
by OpCo
|
|
239,706
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
239,706
|
|
||||||||
Balance as of August 4, 2014 (prior to
initial public offering)
|
|
$
|
608,371
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
608,371
|
|
Allocation of net investment to unitholders
|
|
(608,371
|
)
|
|
—
|
|
|
3,563
|
|
|
31,479
|
|
|
—
|
|
|
—
|
|
|
573,329
|
|
|
—
|
|
||||||||
Proceeds from initial public offering, net
of finance and other offering costs
|
|
—
|
|
|
286,088
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
286,088
|
|
||||||||
Distribution to the noncontrolling interest
in OpCo |
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(151,729
|
)
|
|
(151,729
|
)
|
||||||||
Purchase of additional interest in OpCo
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(242,572
|
)
|
|
—
|
|
|
242,572
|
|
|
—
|
|
||||||||
Net income
|
|
—
|
|
|
6,493
|
|
|
720
|
|
|
6,364
|
|
|
—
|
|
|
—
|
|
|
134,909
|
|
|
148,486
|
|
||||||||
Quarterly distribution to unitholders
|
|
—
|
|
|
(2,204
|
)
|
|
(245
|
)
|
|
(2,162
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(4,611
|
)
|
||||||||
Quarterly distribution to noncontrolling
interest retained in OpCo by Westlake
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(51,655
|
)
|
|
(51,655
|
)
|
||||||||
Balances at December 31, 2014
|
|
$
|
—
|
|
|
$
|
290,377
|
|
|
$
|
4,038
|
|
|
$
|
35,681
|
|
|
$
|
(242,572
|
)
|
|
$
|
—
|
|
|
$
|
747,426
|
|
|
$
|
834,950
|
|
Net income
|
|
—
|
|
|
19,044
|
|
|
2,114
|
|
|
18,673
|
|
|
—
|
|
|
—
|
|
|
314,022
|
|
|
353,853
|
|
||||||||
Net effect of cash flow hedge
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
280
|
|
|
—
|
|
|
280
|
|
||||||||
Quarterly distribution to unitholders
|
|
—
|
|
|
(14,856
|
)
|
|
(1,650
|
)
|
|
(14,568
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(31,074
|
)
|
||||||||
Quarterly distribution to noncontrolling
interest retained in OpCo by Westlake
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(310,842
|
)
|
|
(310,842
|
)
|
||||||||
Balances at December 31, 2015
|
|
$
|
—
|
|
|
$
|
294,565
|
|
|
$
|
4,502
|
|
|
$
|
39,786
|
|
|
$
|
(242,572
|
)
|
|
$
|
280
|
|
|
$
|
750,606
|
|
|
$
|
847,167
|
|
Net income
|
|
—
|
|
|
19,440
|
|
|
2,157
|
|
|
19,062
|
|
|
281
|
|
|
—
|
|
|
312,463
|
|
|
353,403
|
|
||||||||
Net effect of cash flow hedge
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(80
|
)
|
|
—
|
|
|
(80
|
)
|
||||||||
Quarterly distribution to unitholders
|
|
—
|
|
|
(16,638
|
)
|
|
(1,846
|
)
|
|
(16,314
|
)
|
|
(139
|
)
|
|
—
|
|
|
—
|
|
|
(34,937
|
)
|
||||||||
Quarterly distribution to noncontrolling
interest retained in OpCo by Westlake
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(244,590
|
)
|
|
(244,590
|
)
|
||||||||
Balances at December 31, 2016
|
|
$
|
—
|
|
|
$
|
297,367
|
|
|
$
|
4,813
|
|
|
$
|
42,534
|
|
|
$
|
(242,430
|
)
|
|
$
|
200
|
|
|
$
|
818,479
|
|
|
$
|
920,963
|
|
|
|
Year Ended December 31,
|
||||||||||
|
|
2016
|
|
2015
|
|
2014
|
||||||
|
|
|
|
|
|
|
||||||
|
|
(in thousands of dollars)
|
||||||||||
Cash flows from operating activities
|
|
|
|
|
|
|
||||||
Net income
|
|
$
|
353,403
|
|
|
$
|
353,853
|
|
|
$
|
509,820
|
|
Adjustments to reconcile net income to net cash provided by
operating activities
|
|
|
|
|
|
|
||||||
Depreciation and amortization
|
|
98,210
|
|
|
81,210
|
|
|
77,611
|
|
|||
Provision for doubtful accounts
|
|
394
|
|
|
170
|
|
|
65
|
|
|||
Loss from disposition of property, plant and equipment
|
|
3,021
|
|
|
1,812
|
|
|
1,544
|
|
|||
Deferred income taxes
|
|
344
|
|
|
(456
|
)
|
|
8,608
|
|
|||
Income from equity method investment, net of dividends
|
|
—
|
|
|
—
|
|
|
1,073
|
|
|||
Changes in operating assets and liabilities
|
|
|
|
|
|
|
||||||
Accounts receivable—third parties
|
|
(552
|
)
|
|
25,424
|
|
|
(31,551
|
)
|
|||
Net accounts receivable—Westlake
|
|
(90,742
|
)
|
|
(11,836
|
)
|
|
(11,059
|
)
|
|||
Inventories
|
|
(55
|
)
|
|
2,755
|
|
|
24,686
|
|
|||
Prepaid expenses and other current assets
|
|
(2
|
)
|
|
(55
|
)
|
|
(624
|
)
|
|||
Accounts payable
|
|
(2,175
|
)
|
|
836
|
|
|
(4,915
|
)
|
|||
Accrued and other liabilities
|
|
3,791
|
|
|
2,317
|
|
|
20,166
|
|
|||
Other, net
|
|
(77,911
|
)
|
|
(3,488
|
)
|
|
8,588
|
|
|||
Net cash provided by operating activities
|
|
287,726
|
|
|
452,542
|
|
|
604,012
|
|
|||
Cash flows from investing activities
|
|
|
|
|
|
|
||||||
Additions to property, plant and equipment
|
|
(299,638
|
)
|
|
(231,185
|
)
|
|
(202,823
|
)
|
|||
Proceeds from disposition of assets
|
|
157
|
|
|
—
|
|
|
—
|
|
|||
Settlements of derivative instruments
|
|
—
|
|
|
—
|
|
|
(133
|
)
|
|||
Net cash used for investing activities
|
|
(299,481
|
)
|
|
(231,185
|
)
|
|
(202,956
|
)
|
|||
Cash flows from financing activities
|
|
|
|
|
|
|
||||||
Proceeds from debt payable to Westlake
|
|
212,175
|
|
|
291,709
|
|
|
181,642
|
|
|||
Repayment of debt payable to Westlake
|
|
(1,552
|
)
|
|
(135,341
|
)
|
|
—
|
|
|||
Quarterly distributions to noncontrolling interest retained in OpCo by
Westlake
|
|
(244,590
|
)
|
|
(310,842
|
)
|
|
(51,655
|
)
|
|||
Quarterly distributions to unitholders
|
|
(34,937
|
)
|
|
(31,074
|
)
|
|
(4,611
|
)
|
|||
Repayment of debt payable to Westlake with proceeds from the initial public
offering
|
|
—
|
|
|
—
|
|
|
(78,940
|
)
|
|||
Net proceeds from issuance of common units
|
|
—
|
|
|
—
|
|
|
286,088
|
|
|||
Proceeds from initial public offering distributed to Westlake
|
|
—
|
|
|
—
|
|
|
(151,729
|
)
|
|||
Net distributions to Westlake prior to initial public offering
|
|
—
|
|
|
—
|
|
|
(448,101
|
)
|
|||
Net cash used for financing activities
|
|
(68,904
|
)
|
|
(185,548
|
)
|
|
(267,306
|
)
|
|||
Net (decrease) increase in cash and cash equivalents
|
|
(80,659
|
)
|
|
35,809
|
|
|
133,750
|
|
|||
Cash and cash equivalents at beginning of the year
|
|
169,559
|
|
|
133,750
|
|
|
—
|
|
|||
Cash and cash equivalents at end of the year
|
|
$
|
88,900
|
|
|
$
|
169,559
|
|
|
$
|
133,750
|
|
•
|
The consolidated statement of operations for the year ended December 31, 2014 consists of the consolidated results of the Partnership for the period from August 4, 2014 through December 31, 2014 and the combined results of the Predecessor for the period from January 1, 2014 through August 3, 2014.
|
•
|
The consolidated statement of cash flows for the year ended December 31, 2014 consists of the consolidated results of the Partnership for the period from August 4, 2014 through December 31, 2014 and the combined results of the Predecessor for the period from January 1, 2014 through August 3, 2014.
|
•
|
The consolidated statement of changes in equity for the year ended December 31, 2014 consists of the combined activity for the Predecessor prior to August 4, 2014, and the consolidated activity for the Partnership at and subsequent to the IPO on August 4, 2014 through December 31, 2014. The combined statement of changes in equity for the year ended December 31, 2013 consists entirely of the combined activity of the Predecessor.
|
Classification
|
|
Years
|
|
|
|
Buildings and improvements
|
25
|
|
Plant and equipment
|
25
|
|
Ethylene pipeline
|
35
|
|
Other
|
3-10
|
•
|
1,436,115
common units and
12,686,115
subordinated units; and
|
•
|
the Partnership's general partner interest and its incentive distribution rights.
|
•
|
the actual price OpCo pays Westlake to purchase ethane (or other feedstock, such as propane, if applicable) to produce each pound of ethylene, subject to a specified cap and a floor on the amount of feedstock that should be needed to produce each pound of ethylene; plus
|
•
|
the actual price OpCo pays Westlake to purchase natural gas to produce each pound of ethylene, subject to a specified cap and a floor on the amount of natural gas that should be needed to produce each pound of ethylene; plus
|
•
|
OpCo's estimated operating costs (including selling, general and administrative expenses), divided by OpCo's planned ethylene production for the year (in pounds); plus
|
•
|
a
five
-year average of OpCo's expected future maintenance capital expenditures and other turnaround expenditures, divided by OpCo's planned ethylene production capacity for the year (in pounds); less
|
•
|
the proceeds (on a per pound of ethylene basis) received by OpCo from the sale of co-products (including, but not limited to, propylene, crude butadiene, pyrolysis gasoline and hydrogen) associated with producing the ethylene purchased by Westlake; plus
|
•
|
a
$0.10
per pound margin.
|
|
|
December 31,
|
||||||
|
|
2016
|
|
2015
|
||||
Trade customers
|
|
$
|
11,913
|
|
|
$
|
12,097
|
|
Allowance for doubtful accounts
|
|
(564
|
)
|
|
(170
|
)
|
||
|
|
11,349
|
|
|
11,927
|
|
||
Other
|
|
736
|
|
|
—
|
|
||
Accounts receivable, net—third parties
|
|
$
|
12,085
|
|
|
$
|
11,927
|
|
|
|
Year Ended December 31,
|
||||||||||
|
|
2016
|
|
2015
|
|
2014
|
||||||
Balance at January 1
|
|
$
|
170
|
|
|
$
|
—
|
|
|
$
|
2,105
|
|
Charged to Expense
|
|
394
|
|
|
170
|
|
|
65
|
|
|||
Deductions
(1)
|
|
—
|
|
|
—
|
|
|
(2,170
|
)
|
|||
Balance at December 31
|
|
$
|
564
|
|
|
$
|
170
|
|
|
$
|
—
|
|
|
|
December 31,
|
||||||
|
|
2016
|
|
2015
|
||||
Finished products
|
|
$
|
3,610
|
|
|
$
|
3,527
|
|
Feedstock, additives and chemicals
|
|
324
|
|
|
352
|
|
||
Inventories
|
|
$
|
3,934
|
|
|
$
|
3,879
|
|
|
|
December 31,
|
||||||
|
|
2016
|
|
2015
|
||||
Building and improvements
|
|
$
|
16,757
|
|
|
$
|
16,124
|
|
Plant and equipment
|
|
1,690,317
|
|
|
1,231,684
|
|
||
Other
|
|
72,215
|
|
|
67,353
|
|
||
|
|
1,779,289
|
|
|
1,315,161
|
|
||
Less: Accumulated depreciation
|
|
(644,070
|
)
|
|
(601,980
|
)
|
||
|
|
1,135,219
|
|
|
713,181
|
|
||
Construction in progress
|
|
87,019
|
|
|
307,288
|
|
||
Property, plant and equipment, net
|
|
$
|
1,222,238
|
|
|
$
|
1,020,469
|
|
|
|
December 31, 2016
|
|
December 31, 2015
|
|
|
||||||||||||||||||||
|
|
Cost
|
|
Accumulated
Amortization
|
|
Net
|
|
Cost
|
|
Accumulated
Amortization
|
|
Net
|
|
Weighted
Average
Life
|
||||||||||||
Goodwill
|
|
$
|
5,814
|
|
|
$
|
—
|
|
|
$
|
5,814
|
|
|
$
|
5,814
|
|
|
$
|
—
|
|
|
$
|
5,814
|
|
|
|
Deferred charges and
other assets
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Interest rate contract
|
|
290
|
|
|
—
|
|
|
290
|
|
|
436
|
|
|
—
|
|
|
436
|
|
|
|
||||||
Turnaround costs
|
|
154,453
|
|
|
(65,268
|
)
|
|
89,185
|
|
|
100,020
|
|
|
(67,767
|
)
|
|
32,253
|
|
|
6
|
||||||
Other
|
|
8,723
|
|
|
(3,187
|
)
|
|
5,536
|
|
|
8,710
|
|
|
(2,620
|
)
|
|
6,090
|
|
|
17
|
||||||
Total deferred charges and
other assets
|
|
163,466
|
|
|
(68,455
|
)
|
|
95,011
|
|
|
109,166
|
|
|
(70,387
|
)
|
|
38,779
|
|
|
|
||||||
Other assets, net
|
|
$
|
169,280
|
|
|
$
|
(68,455
|
)
|
|
$
|
100,825
|
|
|
$
|
114,980
|
|
|
$
|
(70,387
|
)
|
|
$
|
44,593
|
|
|
|
|
|
December 31,
|
||||||
|
|
2016
|
|
2015
|
||||
August 2013 Promissory Notes (variable interest rate of prime plus 1.5%, original
scheduled maturity of August 1, 2023)
|
|
$
|
31,775
|
|
|
$
|
31,775
|
|
OpCo Revolver (variable interest rate of London Interbank Offered Rate ("LIBOR") plus
3.0%, original scheduled maturity of August 4, 2019)
|
|
427,513
|
|
|
216,890
|
|
||
MLP Revolver (variable interest rate of LIBOR plus 2.0%, original scheduled maturity of
April 29, 2018)
|
|
135,341
|
|
|
135,341
|
|
||
Long-term debt payable to Westlake
|
|
$
|
594,629
|
|
|
$
|
384,006
|
|
|
|
Marginal Percentage Interest in Distributions
|
||||
Total Quarterly Distribution Per Unit
|
|
Unitholders
|
|
IDR Holders
|
||
Above $0.3163 up to $0.3438
|
|
85.0
|
%
|
|
15.0
|
%
|
Above $0.3438 up to $0.4125
|
|
75.0
|
%
|
|
25.0
|
%
|
Above $0.4125
|
|
50.0
|
%
|
|
50.0
|
%
|
|
|
Year Ended December 31
|
||||||||||
|
|
2016
|
|
2015
|
|
2014
|
||||||
Net income attributable to the Partnership
|
|
$
|
40,940
|
|
|
$
|
39,831
|
|
|
$
|
13,577
|
|
Less:
|
|
|
|
|
|
|
||||||
Limited partners' distribution declared on common units
|
|
19,016
|
|
|
16,980
|
|
|
6,403
|
|
|||
Limited partners' distribution declared on subordinated units
|
|
16,784
|
|
|
14,986
|
|
|
5,649
|
|
|||
Distributions declared with respect to the incentive distribution rights
|
|
281
|
|
|
—
|
|
|
—
|
|
|||
Net income in excess of distribution
|
|
$
|
4,859
|
|
|
$
|
7,865
|
|
|
$
|
1,525
|
|
|
|
December 31, 2016
|
||||||||||||||
|
|
Limited Partners' Common Units
|
|
Limited Partners' Subordinated Units
|
|
Incentive Distribution Rights
|
|
Total
|
||||||||
Net income attributable to the Partnership:
|
|
|
|
|
|
|
|
|
||||||||
Distribution
|
|
$
|
19,016
|
|
|
$
|
16,784
|
|
|
$
|
281
|
|
|
$
|
36,081
|
|
Net income in excess of distribution
|
|
2,581
|
|
|
2,278
|
|
|
—
|
|
|
4,859
|
|
||||
Net income
|
|
$
|
21,597
|
|
|
$
|
19,062
|
|
|
$
|
281
|
|
|
$
|
40,940
|
|
Weighted average units outstanding:
|
|
|
|
|
|
|
|
|
||||||||
Basic and diluted
|
|
14,373,615
|
|
|
12,686,115
|
|
|
|
|
27,059,730
|
|
|||||
Net income per limited partner unit:
|
|
|
|
|
|
|
|
|
||||||||
Basic and diluted
|
|
$
|
1.50
|
|
|
$
|
1.50
|
|
|
|
|
|
|
|
December 31, 2015
|
||||||||||||||
|
|
Limited Partners' Common Units
|
|
Limited Partners' Subordinated Units
|
|
Incentive Distribution Rights
|
|
Total
|
||||||||
Net income attributable to the Partnership:
|
|
|
|
|
|
|
|
|
||||||||
Distribution
|
|
$
|
16,980
|
|
|
$
|
14,986
|
|
|
$
|
—
|
|
|
$
|
31,966
|
|
Net income in excess of distribution
|
|
4,178
|
|
|
3,687
|
|
|
—
|
|
|
7,865
|
|
||||
Net income
|
|
$
|
21,158
|
|
|
$
|
18,673
|
|
|
$
|
—
|
|
|
$
|
39,831
|
|
Weighted average units outstanding:
|
|
|
|
|
|
|
|
|
||||||||
Basic and diluted
|
|
14,373,615
|
|
|
12,686,115
|
|
|
|
|
27,059,730
|
|
|||||
Net income per limited partner unit:
|
|
|
|
|
|
|
|
|
||||||||
Basic and diluted
|
|
$
|
1.47
|
|
|
$
|
1.47
|
|
|
|
|
|
|
|
December 31, 2014
|
||||||||||||||
|
|
Limited Partners' Common Units
|
|
Limited Partners' Subordinated Units
|
|
Incentive Distribution Rights
|
|
Total
|
||||||||
Net income attributable to the Partnership:
|
|
|
|
|
|
|
|
|
||||||||
Distribution
|
|
$
|
6,403
|
|
|
$
|
5,649
|
|
|
$
|
—
|
|
|
$
|
12,052
|
|
Net income in excess of distribution
|
|
810
|
|
|
715
|
|
|
—
|
|
|
1,525
|
|
||||
Net income
|
|
$
|
7,213
|
|
|
$
|
6,364
|
|
|
$
|
—
|
|
|
$
|
13,577
|
|
Weighted average units outstanding:
|
|
|
|
|
|
|
|
|
||||||||
Basic and diluted
|
|
14,373,615
|
|
|
12,686,115
|
|
|
|
|
27,059,730
|
|
|||||
Net income per limited partner unit:
|
|
|
|
|
|
|
|
|
||||||||
Basic and diluted
|
|
$
|
0.50
|
|
|
$
|
0.50
|
|
|
|
|
|
|
|
Year Ended December 31,
|
||||||||||
|
|
2016
|
|
2015
|
|
2014
|
||||||
Net sales—Westlake
|
|
$
|
853,719
|
|
|
$
|
834,918
|
|
|
$
|
1,292,089
|
|
|
|
Year Ended December 31,
|
||||||||||
|
|
2016
|
|
2015
|
|
2014
|
||||||
Feedstock purchased from Westlake and included in cost of sales
|
|
$
|
287,778
|
|
|
$
|
307,582
|
|
|
$
|
155,232
|
|
Other charges from Westlake and included in cost of sales
|
|
85,872
|
|
|
74,050
|
|
|
60,264
|
|
|||
Total
|
|
$
|
373,650
|
|
|
$
|
381,632
|
|
|
$
|
215,496
|
|
|
|
Year Ended December 31,
|
||||||||||
|
|
2016
|
|
2015
|
|
2014
|
||||||
Services received from Westlake and included in selling,
general and administrative expenses
|
|
$
|
21,971
|
|
|
$
|
20,681
|
|
|
$
|
21,302
|
|
|
|
Year Ended December 31,
|
||||||||||
|
|
2016
|
|
2015
|
|
2014
|
||||||
Goods and services purchased from Westlake and capitalized as assets
|
|
$
|
17,874
|
|
|
$
|
4,332
|
|
|
$
|
5,823
|
|
|
|
December 31,
|
||||||
|
|
2016
|
|
2015
|
||||
Accounts receivable, net—Westlake
|
|
$
|
126,977
|
|
|
$
|
39,655
|
|
Accounts payable—Westlake
|
|
12,130
|
|
|
15,550
|
|
|
|
December 31,
|
||||||
|
|
2016
|
|
2015
|
||||
Long-term debt payable to Westlake
|
|
$
|
594,629
|
|
|
$
|
384,006
|
|
|
|
Year Ended December 31,
|
||||||
|
|
2016
|
|
2015
|
||||
Balance at January 1
|
|
$
|
280
|
|
|
$
|
—
|
|
Interest rate contract - Other comprehensive income before reclassifications
|
|
(416
|
)
|
|
85
|
|
||
Interest rate contract - Amounts reclassified to net income
|
|
336
|
|
|
195
|
|
||
Balance at December 31
|
|
$
|
200
|
|
|
$
|
280
|
|
|
|
Number of Units
|
|
Weighted
Average Fair Value
|
|||
Non-vested balance at December 31, 2014
|
|
4,404
|
|
|
$
|
29.49
|
|
Granted
|
|
12,559
|
|
|
20.57
|
|
|
Non-vested balance at December 31, 2015
|
|
16,963
|
|
|
22.89
|
|
|
Granted
|
|
9,900
|
|
|
22.91
|
|
|
Vested
|
|
(5,543
|
)
|
|
23.38
|
|
|
Non-vested balance at December 31, 2016
|
|
21,320
|
|
|
22.77
|
|
Derivatives Not Designated as
Hedging Instruments
|
|
Location of Gain (Loss)
Recognized in Income on Derivative
|
|
Year Ended December 31, 2014
|
||
Commodity forward contracts
|
|
Cost of sales
|
|
$
|
(9,244
|
)
|
|
|
Derivative Asset
|
||||||||
Derivative in Cash Flow Hedging Relationship
|
|
Balance Sheet Location
|
|
Fair Value as of
December 31,
2016
|
|
Fair Value as of
December 31,
2015
|
||||
Interest rate contract
|
|
Deferred charges and other assets, net
|
|
$
|
290
|
|
|
$
|
436
|
|
Derivative in Cash Flow Hedging Relationship
|
|
Location of Gain (Loss)
Recognized in Statement of Operations |
|
Year Ended December 31, 2016
|
|
Year Ended December 31, 2015
|
||||
Interest rate contract—Loss reclassified
from accumulated other comprehensive
income to net income
|
|
Interest expense
|
|
$
|
(336
|
)
|
|
$
|
(195
|
)
|
Derivative in Cash Flow Hedging Relationship
|
|
Year Ended December 31, 2016
|
|
Year Ended December 31, 2015
|
|||||
Interest rate contract—Adjustments to fair value recognized in other comprehensive
income
|
|
$
|
(416
|
)
|
|
$
|
85
|
|
|
|
December 31, 2016
|
||||||
|
|
Level 2
|
|
Total
|
||||
Derivative instruments
|
|
|
|
|
||||
Asset—Interest rate contract
|
|
$
|
290
|
|
|
$
|
290
|
|
|
|
December 31, 2015
|
||||||
|
|
Level 2
|
|
Total
|
||||
Derivative instruments
|
|
|
|
|
||||
Asset—Interest rate contract
|
|
$
|
436
|
|
|
$
|
436
|
|
|
|
December 31, 2016
|
|
December 31, 2015
|
||||||||||
|
|
Carrying
Value
|
|
Fair
Value
|
|
Carrying
Value
|
|
Fair
Value
|
||||||
August 2013 Promissory Notes
|
|
$
|
31,775
|
|
|
$
|
31,775
|
|
|
31,775
|
|
|
31,775
|
|
OpCo Revolver
|
|
427,513
|
|
|
442,716
|
|
|
216,890
|
|
|
215,738
|
|
||
MLP Revolver
|
|
135,341
|
|
|
134,835
|
|
|
135,341
|
|
|
130,439
|
|
|
|
Partnership
|
|
Predecessor
|
||||||||||||
|
|
Year Ended December 31, 2016
|
|
Year Ended December 31, 2015
|
|
Period from August 4, 2014 to December 31, 2014
|
|
Period from January 1, 2014 to August 3, 2014
|
||||||||
Current
|
|
|
|
|
|
|
|
|
||||||||
Federal
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
168,773
|
|
State and local
|
|
691
|
|
|
1,128
|
|
|
800
|
|
|
21,207
|
|
||||
|
|
691
|
|
|
1,128
|
|
|
800
|
|
|
189,980
|
|
||||
Deferred
|
|
|
|
|
|
|
|
|
||||||||
Federal
|
|
—
|
|
|
—
|
|
|
—
|
|
|
6,890
|
|
||||
State and local
|
|
344
|
|
|
(456
|
)
|
|
265
|
|
|
1,453
|
|
||||
|
|
344
|
|
|
(456
|
)
|
|
265
|
|
|
8,343
|
|
||||
Total provision
|
|
$
|
1,035
|
|
|
$
|
672
|
|
|
$
|
1,065
|
|
|
$
|
198,323
|
|
|
|
Partnership
|
|
Predecessor
|
||||||||||||
|
|
Year Ended December 31, 2016
|
|
Year Ended December 31, 2015
|
|
Period from August 4, 2014 to December 31, 2014
|
|
Period from January 1, 2014 to August 3, 2014
|
||||||||
Provision for federal income tax, at statutory rate
|
|
$
|
124,054
|
|
|
$
|
124,083
|
|
|
$
|
52,343
|
|
|
$
|
195,880
|
|
State income tax provision, net of federal income tax
effect
|
|
1,035
|
|
|
672
|
|
|
1,065
|
|
|
14,729
|
|
||||
Partnership income not subject to entity-level federal
income tax
|
|
(124,054
|
)
|
|
(124,083
|
)
|
|
(52,343
|
)
|
|
—
|
|
||||
Manufacturing deduction
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(12,214
|
)
|
||||
Other, net
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(72
|
)
|
||||
Total provision
|
|
$
|
1,035
|
|
|
$
|
672
|
|
|
$
|
1,065
|
|
|
$
|
198,323
|
|
|
|
December 31,
|
||||||
|
|
2016
|
|
2015
|
||||
Property, plant and equipment
|
|
$
|
(1,488
|
)
|
|
$
|
(1,291
|
)
|
Turnaround costs
|
|
(248
|
)
|
|
(101
|
)
|
||
Total deferred tax liabilities
|
|
$
|
(1,736
|
)
|
|
$
|
(1,392
|
)
|
|
|
|
|
|
||||
Balance sheet classifications
|
|
|
|
|
||||
Noncurrent deferred tax liability
|
|
$
|
(1,736
|
)
|
|
$
|
(1,392
|
)
|
Total deferred tax liabilities
|
|
$
|
(1,736
|
)
|
|
$
|
(1,392
|
)
|
2017
|
$
|
1,144
|
|
2018
|
907
|
|
|
2019
|
839
|
|
|
2020
|
771
|
|
|
2021
|
656
|
|
|
Thereafter
|
383
|
|
|
|
$
|
4,700
|
|
|
|
Three Months Ended
|
||||||||||||||
|
|
March 31,
2016 |
|
June 30,
2016 |
|
September 30,
2016 |
|
December 31,
2016 |
||||||||
Net sales
|
|
$
|
252,604
|
|
|
$
|
210,841
|
|
|
$
|
229,354
|
|
|
$
|
293,937
|
|
Gross profit
|
|
110,414
|
|
|
88,381
|
|
|
86,801
|
|
|
105,735
|
|
||||
Income from operations
|
|
104,317
|
|
|
82,533
|
|
|
81,013
|
|
|
98,581
|
|
||||
Net income
|
|
102,771
|
|
|
81,192
|
|
|
75,859
|
|
|
93,581
|
|
||||
Net income attributable to Westlake Chemical Partners LP
|
|
12,084
|
|
|
9,344
|
|
|
8,661
|
|
|
10,851
|
|
||||
Net income attributable to Westlake Chemical Partners LP
|
|
|
|
|
|
|
|
|
||||||||
Basic and diluted earnings per common unitholder
|
|
$
|
0.45
|
|
|
$
|
0.34
|
|
|
$
|
0.32
|
|
|
$
|
0.39
|
|
Basic and diluted earnings per subordinated unitholder
|
|
$
|
0.45
|
|
|
$
|
0.34
|
|
|
$
|
0.32
|
|
|
$
|
0.39
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
|
Three Months Ended
|
||||||||||||||
|
|
March 31,
2015 |
|
June 30,
2015 |
|
September 30,
2015 |
|
December 31,
2015 |
||||||||
|
|
|
|
|
|
|
|
|
||||||||
Net sales
|
|
$
|
258,391
|
|
|
$
|
251,705
|
|
|
$
|
248,619
|
|
|
$
|
248,506
|
|
Gross profit
|
|
96,227
|
|
|
94,528
|
|
|
94,145
|
|
|
97,982
|
|
||||
Income from operations
|
|
90,227
|
|
|
88,533
|
|
|
88,314
|
|
|
92,258
|
|
||||
Net income
|
|
88,389
|
|
|
87,243
|
|
|
87,046
|
|
|
91,175
|
|
||||
Net income attributable to Westlake Chemical Partners LP
|
|
8,500
|
|
|
10,443
|
|
|
10,103
|
|
|
10,785
|
|
||||
Net income attributable to Westlake Chemical Partners LP
|
|
|
|
|
|
|
|
|
||||||||
Basic and diluted earnings per common unitholder
|
|
$
|
0.31
|
|
|
$
|
0.39
|
|
|
$
|
0.37
|
|
|
$
|
0.40
|
|
Basic and diluted earnings per subordinated unitholder
|
|
$
|
0.31
|
|
|
$
|
0.39
|
|
|
$
|
0.37
|
|
|
$
|
0.40
|
|
Name
|
|
Age
(as of December 31, 2016)
|
|
Position With Our General Partner
|
Albert Chao
|
|
67
|
|
President, Chief Executive Officer and Director
|
James Chao
|
|
69
|
|
Chairman of the Board of Directors
|
M. Steven Bender
|
|
60
|
|
Senior Vice President, Chief Financial Officer, Treasurer and Director
|
L. Benjamin Ederington
|
|
46
|
|
Vice President, General Counsel and Director
|
George Mangieri
|
|
66
|
|
Vice President and Chief Accounting Officer
|
Lawrence Teel
|
|
58
|
|
Senior Vice President, Olefins
|
Max L. Lukens
|
|
68
|
|
Director
|
David Lumpkins
|
|
62
|
|
Director
|
Angela Minas
|
|
52
|
|
Director
|
Air Products and Chemicals, Inc.
|
|
Huntsman Corporation
|
Albemarle Corporation
|
|
The Mosaic Company
|
Ashland Inc.
|
|
Olin Corporation
|
Axalta Coating Systems Ltd.
|
|
PolyOne Corporation
|
Celanese Corporation
|
|
Praxair, Inc.
|
CF Industries Holdings, Inc.
|
|
RPM International Inc
|
The Chemours Company
|
|
The Sherwin-Williams Company
|
Eastman Chemical Company
|
|
Trinseo S.A.
|
FMC Corporation
|
|
The Valspar Corporation
|
•
|
attracting, rewarding and retaining top executive talent in support of Westlake's vision, mission and objectives;
|
•
|
maintaining market competitiveness with Westlake's peer group compensation programs and practices;
|
•
|
encouraging and rewarding the achievement of specific individual, business segment and corporate goals and objectives;
|
•
|
placing a significant portion of total compensation at risk through variable pay components, including upside potential where targeted objectives are exceeded, to promote management action to create added stockholder value;
|
•
|
aligning management interests with the interests of the stockholders; and
|
•
|
balancing short-term objectives with long-term strategic initiatives and thinking through the design of both short-term and long-term pay programs.
|
•
|
ensure internal equity;
|
•
|
recognize individual performance and contributions; or
|
•
|
recognize changes in responsibility or the scope of the Westlake Executive's position.
|
Name and Principal Position
|
|
Year
|
|
Base Salary
(1)
|
|
Portion Allocation
(2)
|
|
Total
(3)
|
|||||
Albert Chao
President and Chief Executive Officer
|
|
2016
|
|
$
|
985,000
|
|
|
10.0
|
%
|
|
$
|
98,500
|
|
|
|
2015
|
|
953,000
|
|
|
10.0
|
%
|
|
95,300
|
|
||
|
|
2014
|
|
925,000
|
|
|
10.0
|
%
|
|
38,104
|
|
||
M. Steven Bender
Senior Vice President
Chief Financial Officer and Treasurer
|
|
2016
|
|
525,000
|
|
|
12.5
|
%
|
|
65,625
|
|
||
|
|
2015
|
|
500,000
|
|
|
12.5
|
%
|
|
62,500
|
|
||
|
|
2014
|
|
462,000
|
|
|
12.5
|
%
|
|
23,732
|
|
(1)
|
See "Compensation Discussion and Analysis—Establishing Compensation Levels—Base Pay" for more information on base salary.
|
(2)
|
See "Compensation Discussion and Analysis—Overview" for more information on the portion of base salary allocated to us by Westlake.
|
(3)
|
Reflects the portion of base salary allocated to us by Westlake for the periods from January 1, 2016 through December 31, 2016, from January 1, 2015 through December 31, 2015 and from August 4, 2014 through December 31, 2014.
|
Name
|
|
Fees Earned or Paid in Cash
|
|
Phantom Unit Awards
(1)
|
|
All Other Compensation
(2)
|
|
Total
|
||||||||
Gary K. Adams
|
|
$
|
48,750
|
|
|
$
|
—
|
|
|
$
|
128,491
|
|
|
$
|
177,241
|
|
Max L. Lukens
|
|
80,000
|
|
|
75,000
|
|
|
8,212
|
|
|
163,212
|
|
||||
David Lumpkins
|
|
65,000
|
|
|
75,000
|
|
|
8,212
|
|
|
148,642
|
|
||||
Angela Minas
|
|
16,250
|
|
|
75,000
|
|
|
1,152
|
|
|
92,402
|
|
(1)
|
The amounts reflected in this column represent the grant date fair value of restricted phantom unit awards granted to the non-employee directors, computed in accordance with FASB ASC Topic 718, as the product of (i) the number of phantom units granted and (ii) the average of the high and low prices of our common units reported on the New York Stock Exchange on the grant date. As of December 31, 2016, Messrs. Lukens and Lumpkins and Ms. Minas held 8,755, 9,109 and 3,436 phantom units, respectively.
|
(2)
|
The amounts reflected in this column represent (a) the amount of cash paid with respect to distribution equivalent rights granted in tandem with the phantom unit awards and (b) with respect to Mr. Adams, an amount ($123,221) awarded by our general partner’s board of directors in November 2016 in recognition of his service on the board and equivalent in value to the phantom units he surrendered upon his retirement from the board in October 2016.
|
•
|
our general partner;
|
•
|
Westlake;
|
•
|
each director and named executive officer of our general partner; and
|
•
|
all of the directors and executive officers of our general partner as a group.
|
Name of Beneficial Owner
|
|
Common Units Beneficially Owned
|
|
Percentage of Common Units Beneficially Owned
|
|
Subordinated Units Beneficially Owned
|
|
Percentage of Subordinated Units Beneficially Owned
|
|
Percentage of Common and Subordinated Units Beneficially Owned
|
|||
Westlake Chemical Corporation
|
|
1,436,115
|
|
|
10.0
|
%
|
|
12,686,115
|
|
100%
|
|
52.2%
|
|
Westlake Chemical Partners GP LLC
|
|
0
|
|
|
0
|
|
|
0
|
|
0
|
|
0
|
|
Albert Chao
|
|
45,000
|
|
|
*
|
|
|
0
|
|
0
|
|
*
|
|
James Chao
|
|
45,000
|
|
|
*
|
|
|
0
|
|
0
|
|
*
|
|
M. Steven Bender
|
|
10,000
|
|
|
*
|
|
|
0
|
|
0
|
|
*
|
|
L. Benjamin Ederington
|
|
10,000
|
|
|
*
|
|
|
0
|
|
0
|
|
*
|
|
Max L. Lukens
|
|
125,000
|
|
|
*
|
|
|
0
|
|
0
|
|
*
|
|
David Lumpkins
|
|
0
|
|
|
0
|
|
|
0
|
|
0
|
|
*
|
|
Angela Minas
|
|
5,000
|
|
|
*
|
|
|
0
|
|
0
|
|
*
|
|
All directors and executive officers
as a group (9 persons)
|
|
247,500
|
|
|
1.7
|
%
|
|
0
|
|
0
|
|
0.9
|
%
|
|
|
Amount and Nature of
Beneficial Ownership of Common Stock
(1)
|
||||||||
Directors and Named Executive Officers of Our General Partner
|
|
Direct
(2)
|
|
Other
|
|
|
|
Percent of Class
|
||
Albert Chao
|
|
945,260
|
|
|
92,010,554
|
|
(3)
|
|
72.0
|
%
|
James Chao
|
|
233,533
|
|
|
92,010,554
|
|
(3)
|
|
71.5
|
%
|
M. Steven Bender
|
|
178,239
|
|
|
0
|
|
|
|
*
|
|
L. Benjamin Ederington
|
|
14,896
|
|
|
0
|
|
|
|
*
|
|
Max L. Lukens
|
|
18,875
|
|
|
0
|
|
|
|
*
|
|
David Lumpkins
|
|
0
|
|
|
0
|
|
|
|
*
|
|
Angela Minas
|
|
0
|
|
|
0
|
|
|
|
*
|
|
All directors and executive officers as a group (9 persons)
|
|
1,428,057
|
|
|
92,010,554
|
|
|
|
72.4
|
%
|
*
|
Less than 1% of the outstanding shares of common stock.
|
(1)
|
None of the shares beneficially owned by the directors or officers are pledged as security.
|
(2)
|
The amounts include shares of common stock that may be acquired within 60 days from March 1, 2017 through the exercise of options held by Mr. Albert Chao (671,242), Mr. James Chao (114,564), Mr. Bender (107,996), Mr. Ederington (9,172) and all directors and executive officers as a group (925,469).
|
(3)
|
Two trusts for the benefit of members of the Chao family, including James Chao and Albert Chao, are the managers of TTWFGP LLC, a Delaware limited liability company, which is the general partner of TTWF LP. The limited partners of TTWF LP are five trusts principally for the benefit of members of the Chao family, including James Chao and Albert Chao and two corporations owned, indirectly or directly, by certain of these trusts and by other entities owned by members of the Chao family, including James Chao and Albert Chao. James Chao, Albert Chao, TTWF LP and TTWFGP LLC share voting and dispositive power with respect to the shares of Westlake's common stock beneficially owned by TTWF LP. James Chao and Albert Chao disclaim beneficial ownership of the 92,010,554 shares held by TTWF LP except to the extent of their respective pecuniary interest therein.
|
Name of Beneficial Owner
|
|
Common Units Beneficially Owned
|
|
Percentage of Common Units Beneficially Owned
|
|
Subordinated Units Beneficially Owned
|
|
Percentage of Subordinated Units Beneficially Owned
|
|
Percentage of Common and Subordinated Units Beneficially Owned
|
|||
Oppenheimer Funds, Inc. and
Oppenheimer SteelPath MLP
Alpha Fund
2 World Financial Center
225 Liberty Street
New York, New York 10282
|
|
3,335,980
(1)
|
|
23.21
|
%
|
|
0
|
|
0
|
%
|
|
12.33
|
%
|
Harvest Fund Advisors LLC
100 W. Lancaster Avenue, Suite 200
Wayne, PA 19087
|
|
1,983,230
(2)
|
|
13.8
|
%
|
|
0
|
|
0
|
%
|
|
7.3
|
%
|
Energy Income Partners, LLC
100 Wright Street
Westport, CT 06880
|
|
777,327
(3)
|
|
5.4
|
%
|
|
0
|
|
0
|
%
|
|
2.9
|
%
|
(1)
|
Based on an Amendment No. 2 to a Schedule 13G filed on January 25, 2017. According to the filing, Oppenheimer Funds, Inc. had shared voting and shared dispositive power over 3,335,980 common units, and Oppenheimer SteelPath MLP Alpha Fund had shared voting and shared dispositive power over 2,690,933 common units.
|
(2)
|
Based on a Schedule 13G filed on February 10, 2017. According to the filing, Harvest Fund Advisors LLC had sole voting and dispositive power over 1,983,230 common units.
|
(3)
|
Based on a Schedule 13G filed on February 14, 2017. According to the filing, Energy Income Partners, LLC had shared voting power and shared dispositive power over 77,327 common units, and each of James J. Murchie, Eva Pao, Linda A. Longville, Saul Ballesteros and John K. Tysseland had shared voting power and shared dispositive power over 777,327 common units.
|
Plan Category
|
|
Number of units
to be issued upon
exercise of outstanding options, warrants and rights (a)
|
|
Weighted-average
exercise price of
outstanding
options, warrants
and rights
(b)
|
|
Number of securities remaining available
for future issuance under equity
compensation plans
(excluding securities
reflected in column (a))
(c)
|
||||
Equity compensation plan approved by security holders
(1)
|
|
21,320
|
|
|
$
|
0
|
|
|
1,248,680
|
|
Equity compensation plan not approved by security holders
|
|
0
|
|
|
N/A
|
|
|
0
|
|
|
Total
|
|
21,320
|
|
|
$
|
—
|
|
|
1,248,680
|
|
(1)
|
Adopted by our general partner’s board of directors in connection with our IPO. Only phantom unit awards have been granted under the LTIP. There is no weighted-average exercise price associated with these awards.
|
•
|
approved by the conflicts committee of our general partner; or
|
•
|
approved by the holders of a majority of our outstanding common units, excluding any such units owned by our general partner or any of its affiliates.
|
|
|
For the year ended December 31,
|
||||||
|
|
2016
|
|
2015
|
||||
Audit fees
(1)
|
|
$
|
703,000
|
|
|
$
|
756,190
|
|
Audit-related fees
|
|
—
|
|
|
—
|
|
||
Tax fees
(2)
|
|
220,082
|
|
|
176,647
|
|
||
All other fees
|
|
—
|
|
|
—
|
|
||
Total
|
|
$
|
923,082
|
|
|
$
|
932,837
|
|
(1)
|
Represents the aggregate fees for professional services rendered for the audit of the Partnership's financial statements for the years ended December 31, 2016 and 2015, respectively. Also includes the review of the consolidated financial statements included in the Partnership's quarterly reports on Form 10-Q.
|
(2)
|
Represents tax services with respect to the preparation of the Partnership's 2015 K-1 statements in 2016, and the preparation of the Partnership’s 2014 K-1 statements in 2015, and compliance services in 2016.
|
Exhibit No.
|
|
Description
|
|
|
|
2.1
|
|
Equity Purchase Agreement by and among Westlake Chemical Partners LP, Westlake Chemical OpCo LP and WPT LLC, dated as of April 29, 2015 (incorporated by reference to Exhibit 2.1 to Westlake Chemical Partners LP's Current Report on Form 8-K, filed on April 30, 2015, File No 001-36567).
|
|
|
|
3.1
|
|
Certificate of Limited Partnership of Westlake Chemical Partners LP (incorporated by reference to Exhibit 3.1 to Westlake Chemical Partners LP's Registration Statement on Form S-1 (File No. 333-195551), filed on April 29, 2014).
|
|
|
|
3.2
|
|
First Amended and Restated Agreement of Limited Partnership of Westlake Chemical Partners LP (incorporated by reference to Exhibit 3.1 to Westlake Chemical Partners LP's Current Report on Form 8-K (File No. 001-36567) filed on August 8, 2014).
|
|
|
|
4.1
|
|
Indenture dated as of January 1, 2006 by and among Westlake Chemical Corporation, the potential subsidiary guarantors listed therein and JPMorgan Chase Bank, National Association, as trustee (incorporated by reference to Exhibit 4.1 to Westlake Chemical Corporation's Current Report on Form 8-K, filed on January 13, 2006, File No. 1-32260).
|
|
|
|
4.2
|
|
Second Supplemental Indenture, dated as of November 1, 2007, among Westlake Chemical Corporation, the Subsidiary Guarantors (as defined therein) and The Bank of New York Trust Company, N.A., as trustee (incorporated by reference to Exhibit 4.2 to Westlake Chemical Corporation's Current Report on Form 8-K, filed on December 18, 2007, File No. 1-32260).
|
|
|
|
4.3
|
|
Third Supplemental Indenture, dated as of July 2, 2010, among Westlake Chemical Corporation, the Subsidiary Guarantors (as defined therein) and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated by reference to Exhibit 4.2 to Westlake Chemical Corporation's Current Report on Form 8-K, filed on July 8, 2010, File No. 1-32260).
|
|
|
|
4.4
|
|
Fourth Supplemental Indenture, dated as of December 2, 2010, among Westlake Chemical Corporation, the Subsidiary Guarantors (as defined therein) and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated by reference to Exhibit 4.2 to Westlake Chemical Corporation's Current Report on Form 8-K, filed on December 8, 2010, File No. 1-32260).
|
|
|
|
4.5
|
|
Fifth Supplemental Indenture, dated as of December 2, 2010, among Westlake Chemical Corporation, the Subsidiary Guarantors (as defined therein) and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated by reference to Exhibit 4.3 to Westlake Chemical Corporation's Current Report on Form 8-K, filed on December 8, 2010, File No. 1-32260).
|
|
|
|
4.6
|
|
Supplemental Indenture, dated as of December 31, 2007, among Westlake Chemical Corporation, WPT LLC, Westlake Polymers LLC, Westlake Petrochemicals LLC, Westlake Styrene LLC, the other subsidiary guarantors party thereto and The Bank of New York Trust Company, N.A. related to the 6 ¾% senior notes (incorporated by reference to Exhibit 4.7 to Westlake Chemical Corporation's Annual Report on Form 10-K for the year ended December 31, 2007, filed on February 20, 2008, File No. 1-32260).
|
|
|
|
4.7
|
|
Sixth Supplemental Indenture, dated as of July 17, 2012, among Westlake Chemical Corporation, the Subsidiary Guarantors (as defined therein) and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated by reference to Exhibit 4.2 to Westlake Chemical Corporation's Current Report on Form 8-K, filed on July 16, 2012, File No. 1-32260).
|
|
|
|
4.8
|
|
Seventh Supplemental Indenture, dated as of February 12, 2013, among Westlake Chemical Corporation, the Subsidiary Guarantors (as defined therein) and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated by reference to Exhibit 4.16 to Westlake Chemical Corporation's Annual Report on Form 10-K for the year ended December 31, 2012, filed on February 22, 2013, File No. 1-32260).
|
|
|
|
4.9
|
|
Supplemental Indenture, dated as of May 1, 2013, among North American Specialty Products LLC, a Delaware limited liability company, Westlake Chemical Corporation, the other Subsidiary Guarantors (as defined therein) and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated by reference to Exhibit 4.2 to Westlake Chemical Corporation's Quarterly Report on Form 8-K, filed on July 31, 2013, File No. 1-32260).
|
|
|
|
4.10
|
|
Supplemental Indenture, dated as of June 1, 2013, among Westlake Pipeline Investments LLC, a Delaware limited liability company, Westlake Chemical Corporation, the other Subsidiary Guarantors (as defined therein) and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated by reference to Exhibit 4.3 to Westlake Chemical Corporation's Quarterly Report on Form 8-K, filed on July 31, 2013, File No. 1-32260).
|
|
|
|
Exhibit No.
|
|
Description
|
4.11
|
|
Supplemental Indenture, dated as of June 1, 2013, among Westlake NG IV Corporation, a Delaware corporation, and Westlake NG V Corporation, a Delaware corporation, Westlake Chemical Corporation, the other Subsidiary Guarantors (as defined therein) and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated by reference to Exhibit 4.4 to Westlake Chemical Corporation's Quarterly Report on Form 8-K filed on July 31, 2013, File No. 1-32260).
|
|
|
|
4.12
|
|
Supplemental Indenture dated as of July 17, 2014 among Westlake Chemical OpCo LP, Westlake Chemical Corporation, the other Subsidiary Guarantors (as defined therein) and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated by reference to Westlake Chemical Corporation's Quarterly Report on Form 10-Q, filed on August 6, 2014, File No. 001-32260).
|
|
|
|
4.13
|
|
Eighth Supplemental Indenture (including the form of the Notes), dated as of August 10, 2016, among Westlake Chemical Corporation, the Guarantors (as defined therein) and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated by reference to Exhibit 4.2 to Westlake Chemical Corporation's Current Report on Form 8-K, filed on August 10, 2016, File No. 001-32260).
|
|
|
|
4.14
|
|
Ninth Supplemental Indenture (including the form of the Notes), dated as of September 7, 2016, among Westlake Chemical Corporation, the Guarantors (as defined therein) and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated by reference to Exhibit 4.2 to Westlake Chemical Corporation's Current Report on Form 8-K, filed on September 7, 2016, File No. 001-32260).
|
|
|
|
4.15
|
|
Indenture dated as of September 8, 2016, among Westlake and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated by reference to Exhibit 4.4 to Westlake Chemical Corporation's Current Report on Form S-3, filed on September 8, 2016, File No. 333-213548).
|
|
|
|
4.16
|
|
Supplemental Indenture, dated as of October 25, 2016, among the Company, the Guaranteeing Subsidiaries (as defined therein) and the other Subsidiary Guarantors (as defined therein) and the Bank of New York Mellon Trust Company, as trustee (incorporated by reference to Exhibit 4.18 to Westlake Chemical Corporation's Annual Report on Form 10-K for the year ended December 31, 2016, filed on February 22, 2017, File No. 001-32260).
|
|
|
|
10.1
|
|
Omnibus Agreement among Westlake Management Services, Inc., Westlake Vinyls Corporation, Westlake Chemical Partners GP LLC, Westlake Chemical Partners LP, WPT LLC, Westlake Petrochemicals LLC, Westlake Vinyls, Inc., Westlake Longview Corporation, Westlake Chemical OpCo GP LLC, Westlake Chemical OpCo LP, Westlake PVC Corporation, Westlake Styrene LLC and Westlake Polymers LLC (incorporated by reference to Exhibit 10.1 to Westlake Chemical Partners LP's Current Report on Form 8-K (File No. 001-36567) filed on August 8, 2014).
|
|
|
|
10.2
|
|
Services and Secondment Agreement by and among Westlake Chemical OpCo LP, Westlake Management Services, Inc., Westlake Vinyls, Inc., WPT LLC and Westlake Petrochemicals LLC (incorporated by reference to Exhibit 10.2 to Westlake Chemical Partners LP's Current Report on Form 8-K (File No. 001-36567) filed on August 8, 2014).
|
|
|
|
10.3
|
|
Feedstock Supply Agreement between Westlake Petrochemicals LLC and Westlake Chemical OpCo LP (incorporated by reference to Exhibit 10.3 to Westlake Chemical Partners LP's Current Report on Form 8-K (File No. 001-36567) filed on August 8, 2014).
|
|
|
|
10.4††
|
|
Ethylene Sales Agreement between Westlake Chemical OpCo LP, WPT LLC, Westlake Vinyls, Inc. and Westlake Petrochemicals LLC (incorporated by reference to Exhibit 10.4 to Westlake Chemical Partners LP's Current Report on Form 8-K (File No. 001-36567) filed on August 8, 2014).
|
|
|
|
10.5
|
|
Site Lease Agreement (Calvert City) between Westlake Vinyls, Inc. and Westlake Chemical OpCo LP (incorporated by reference to Exhibit 10.5 to Westlake Chemical Partners LP's Current Report on Form 8-K (File No. 001-36567) filed on August 8, 2014).
|
|
|
|
10.6
|
|
Site Lease Agreement (Lake Charles) between Westlake Petrochemical LLC and Westlake Chemical OpCo LP (incorporated by reference to Exhibit 10.6 to Westlake Chemical Partners LP's Current Report on Form 8-K (File No. 001-36567) filed on August 8, 2014).
|
|
|
|
10.7
|
|
Amended and Restated Limited Partnership Agreement of Westlake Chemical OpCo LP (incorporated by reference to Exhibit 10.7 to Westlake Chemical Partners LP's Current Report on Form 8-K (File No. 001-36567) filed on August 8, 2014).
|
|
|
|
Exhibit No.
|
|
Description
|
10.8†
|
|
Westlake Chemical Partners LP Long-Term Incentive Plan (incorporated by reference to Exhibit 10.8 to Westlake Chemical Partners LP's Current Report on Form 8-K (File No. 001-36567) filed on August 8, 2014).
|
|
|
|
10.9†
|
|
Form of Phantom Unit Agreement under the Westlake Chemical Partners LP Long-Term Incentive Plan (incorporated by reference to Exhibit 10.14 to Amendment 4 to Westlake Chemical Partner LP's Registration Statement on Form S-1 (File No. 333-195551) filed on July 15, 2014).
|
|
|
|
10.10†*
|
|
Form of Global Amendment to Phantom Unit Agreements under the Westlake Chemical Partners LP Long-Term Incentive Plan.
|
|
|
|
10.11†*
|
|
Form of Phantom Unit Agreement.
|
|
|
|
10.12
|
|
Intercompany Revolving Credit Agreement between Westlake Chemical OpCo LP and Westlake Development Corporation (incorporated by reference to Exhibit 10.9 to Westlake Chemical Partners LP's Current Report on Form 8-K (File No. 001-36567) filed on August 8, 2014).
|
|
|
|
10.13
|
|
Unsecured Promissory Note between WPT LLC and Westlake Development Corporation (incorporated by reference to Exhibit 10.8 to Westlake Chemical Partners LP's Registration Statement on Form S-1 (File No. 333-195551), filed on June 30, 2014).
|
|
|
|
10.14***
|
|
Unsecured Promissory Note between Westlake Vinyls, Inc. and Westlake Development Corporation.
|
|
|
|
10.15***
|
|
Unsecured Promissory Note between Westlake Petrochemicals LLC and Westlake Development Corporation.
|
|
|
|
10.16
|
|
Senior Unsecured Revolving Credit Agreement by and among Westlake Chemical Partners GP LLC and Westlake Chemical Finance Corporation, dated as of April 29, 2015 (incorporated by reference to Exhibit 10.1 to Westlake Chemical Partners LP's Current Report on Form 8-K, filed on April 30, 2015, File No. 001-36567).
|
|
|
|
10.17
|
|
Credit Agreement, dated as of August 10, 2016, by and between Bank of America, N.A. and Westlake International Holdings II C.V. (incorporated by reference to Exhibit 10.3 to Westlake Chemical Corporation's Quarterly Report on Form 10-Q for the quarter ended September 30, 2016, and filed on November 9, 2016, File No. 001-32260).
|
|
|
|
10.18
|
|
Credit Agreement, dated as of August 23, 2016, by and among Westlake Chemical Corporation, the other borrowers and guarantors referred to therein, the lenders from time to time party thereto, the issuing banks party thereto and JPMorgan Chase Bank, National Association, as Administrative Agent, relating to a $1 billion senior unsecured revolving credit facility (incorporated by reference to Exhibit 10.1 to Westlake Chemical Corporation's Current Report on Form 8-K, filed on August 24, 2016, File No. 001-32260).
|
|
|
|
10.19
|
|
First Amendment to Ethylene Sales Agreement (incorporated herein by reference to Exhibit 10.1 to Westlake Chemical Partners LP's Quarterly Report on Form 10-Q for the quarter ended June 30, 2016, filed on August 9, 2016, File No. 1-32260)
|
|
|
|
10.20*
|
|
Exchange Agreement, effective as of August 1, 2014, by and between WPT LLC and Westlake Chemical OpCo LP.
|
|
|
|
21.1*
|
|
List of Subsidiaries of Westlake Chemical Partners LP.
|
|
|
|
23.1*
|
|
Consent of PricewaterhouseCoopers LLP.
|
|
|
|
31.1*
|
|
Rule 13a - 14(a) / 15d - 14(a) Certification (Principal Executive Officer).
|
|
|
|
31.2*
|
|
Rule 13a - 14(a) / 15d - 14(a) Certification (Principal Financial Officer).
|
|
|
|
32.1**
|
|
Section 1350 Certification (Principal Executive Officer and Principal Financial Officer).
|
|
|
|
101.INS*
|
|
XBRL Instance Document.
|
|
|
|
101.SCH*
|
|
XBRL Taxonomy Extension Schema Document.
|
|
|
|
101.CAL*
|
|
XBRL Taxonomy Extension Calculation Linkbase Document.
|
|
|
|
101.DEF*
|
|
XBRL Taxonomy Extension Definition Linkbase Document.
|
|
|
|
101.LAB*
|
|
XBRL Taxonomy Extension Label Linkbase Document.
|
|
|
|
101.PRE*
|
|
XBRL Taxonomy Extension Presentation Linkbase Document.
|
*
|
Filed herewith.
|
**
|
Furnished herewith.
|
***
|
The Unsecured Promissory Notes between Westlake Development Corporation and each of Westlake Vinyls, Inc. and Westlake Petrochemicals LLC are not filed because they are identical to Exhibit 10.13 except for the identity of the borrower.
|
†
|
Management contract or compensatory plan or arrangement.
|
††
|
Confidential status has been granted for certain portions thereof pursuant to the Order Granting Confidential Treatment Under the Securities Act of 1933 issued by the Division of Corporation Finance of the Securities and Exchange Commission filed on August 1, 2014.
|
|
|
|
WESTLAKE CHEMICAL PARTNERS LP
|
|
|
|
|
Date:
|
March 7, 2017
|
|
/s/ A
LBERT
C
HAO
|
|
|
|
Albert Chao
President, Chief Executive Officer and Director of
Westlake Chemical Partners GP LLC
(Principal Executive Officer)
|
Signature
|
|
Title
|
|
Date
|
|
|
|
||
/
S
/ A
LBERT
C
HAO
|
|
President, Chief Executive Officer and Director
(Principal Executive Officer)
|
|
March 7, 2017
|
Albert Chao
|
|
|||
|
|
|
||
/
S
/ M. S
TEVEN
B
ENDER
|
|
Senior Vice President, Chief Financial Officer,
Director (Principal Financial Officer)
|
|
March 7, 2017
|
M. Steven Bender
|
|
|||
|
|
|
||
/
S
/ G
EORGE
J. M
ANGIERI
|
|
Vice President and Chief Accounting Officer
(Principal Accounting Officer)
|
|
March 7, 2017
|
George J. Mangieri
|
|
|||
|
|
|
||
/
S
/ L. B
ENJAMIN
E
DERINGTON
|
|
Vice President, General Counsel, Secretary
and Director
|
|
March 7, 2017
|
L. Benjamin Ederington
|
|
|||
|
|
|
|
|
/
S
/ J
AMES
C
HAO
|
|
Chairman of the Board of Directors
|
|
March 7, 2017
|
James Chao
|
|
|||
|
|
|
||
/
S
/ M
AX
L. L
UKENS
|
|
Director
|
|
March 7, 2017
|
Max L. Lukens
|
|
|||
|
|
|
|
|
/
S
/ D
AVID
L
UMPKINS
|
|
Director
|
|
March 7, 2017
|
David Lumpkins
|
|
|||
|
|
|
||
/S/ A
NGELA
M
INAS
|
|
Director
|
|
March 7, 2017
|
Angela Minas
|
|
Exhibit No.
|
|
Description
|
|
|
|
2.1
|
|
Equity Purchase Agreement by and among Westlake Chemical Partners LP, Westlake Chemical OpCo LP and WPT LLC, dated as of April 29, 2015 (incorporated by reference to Exhibit 2.1 to Westlake Chemical Partners LP's Current Report on Form 8-K, filed on April 30, 2015, File No 001-36567).
|
|
|
|
3.1
|
|
Certificate of Limited Partnership of Westlake Chemical Partners LP (incorporated by reference to Exhibit 3.1 to Westlake Chemical Partners LP's Registration Statement on Form S-1 (File No. 333-195551), filed on April 29, 2014).
|
|
|
|
3.2
|
|
First Amended and Restated Agreement of Limited Partnership of Westlake Chemical Partners LP (incorporated by reference to Exhibit 3.1 to Westlake Chemical Partners LP's Current Report on Form 8-K (File No. 001-36567) filed on August 8, 2014).
|
|
|
|
4.1
|
|
Indenture dated as of January 1, 2006 by and among Westlake Chemical Corporation, the potential subsidiary guarantors listed therein and JPMorgan Chase Bank, National Association, as trustee (incorporated by reference to Exhibit 4.1 to Westlake Chemical Corporation's Current Report on Form 8-K, filed on January 13, 2006, File No. 1-32260).
|
|
|
|
4.2
|
|
Second Supplemental Indenture, dated as of November 1, 2007, among Westlake Chemical Corporation, the Subsidiary Guarantors (as defined therein) and The Bank of New York Trust Company, N.A., as trustee (incorporated by reference to Exhibit 4.2 to Westlake Chemical Corporation's Current Report on Form 8-K, filed on December 18, 2007, File No. 1-32260).
|
|
|
|
4.3
|
|
Third Supplemental Indenture, dated as of July 2, 2010, among Westlake Chemical Corporation, the Subsidiary Guarantors (as defined therein) and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated by reference to Exhibit 4.2 to Westlake Chemical Corporation's Current Report on Form 8-K, filed on July 8, 2010, File No. 1-32260).
|
|
|
|
4.4
|
|
Fourth Supplemental Indenture, dated as of December 2, 2010, among Westlake Chemical Corporation, the Subsidiary Guarantors (as defined therein) and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated by reference to Exhibit 4.2 to Westlake Chemical Corporation's Current Report on Form 8-K, filed on December 8, 2010, File No. 1-32260).
|
|
|
|
4.5
|
|
Fifth Supplemental Indenture, dated as of December 2, 2010, among Westlake Chemical Corporation, the Subsidiary Guarantors (as defined therein) and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated by reference to Exhibit 4.3 to Westlake Chemical Corporation's Current Report on Form 8-K, filed on December 8, 2010, File No. 1-32260).
|
|
|
|
4.6
|
|
Supplemental Indenture, dated as of December 31, 2007, among Westlake Chemical Corporation, WPT LLC, Westlake Polymers LLC, Westlake Petrochemicals LLC, Westlake Styrene LLC, the other subsidiary guarantors party thereto and The Bank of New York Trust Company, N.A. related to the 6 ¾% senior notes (incorporated by reference to Exhibit 4.7 to Westlake Chemical Corporation's Annual Report on Form 10-K for the year ended December 31, 2007, filed on February 20, 2008, File No. 1-32260).
|
|
|
|
4.7
|
|
Sixth Supplemental Indenture, dated as of July 17, 2012, among Westlake Chemical Corporation, the Subsidiary Guarantors (as defined therein) and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated by reference to Exhibit 4.2 to Westlake Chemical Corporation's Current Report on Form 8-K, filed on July 16, 2012, File No. 1-32260).
|
|
|
|
4.8
|
|
Seventh Supplemental Indenture, dated as of February 12, 2013, among Westlake Chemical Corporation, the Subsidiary Guarantors (as defined therein) and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated by reference to Exhibit 4.16 to Westlake Chemical Corporation's Annual Report on Form 10-K for the year ended December 31, 2012, filed on February 22, 2013, File No. 1-32260).
|
|
|
|
4.9
|
|
Supplemental Indenture, dated as of May 1, 2013, among North American Specialty Products LLC, a Delaware limited liability company, Westlake Chemical Corporation, the other Subsidiary Guarantors (as defined therein) and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated by reference to Exhibit 4.2 to Westlake Chemical Corporation's Quarterly Report on Form 8-K, filed on July 31, 2013, File No. 1-32260).
|
|
|
|
4.10
|
|
Supplemental Indenture, dated as of June 1, 2013, among Westlake Pipeline Investments LLC, a Delaware limited liability company, Westlake Chemical Corporation, the other Subsidiary Guarantors (as defined therein) and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated by reference to Exhibit 4.3 to Westlake Chemical Corporation's Quarterly Report on Form 8-K, filed on July 31, 2013, File No. 1-32260).
|
Exhibit No.
|
|
Description
|
|
|
|
4.11
|
|
Supplemental Indenture, dated as of June 1, 2013, among Westlake NG IV Corporation, a Delaware corporation, and Westlake NG V Corporation, a Delaware corporation, Westlake Chemical Corporation, the other Subsidiary Guarantors (as defined therein) and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated by reference to Exhibit 4.4 to Westlake Chemical Corporation's Quarterly Report on Form 8-K filed on July 31, 2013, File No. 1-32260).
|
|
|
|
4.12
|
|
Supplemental Indenture dated as of July 17, 2014 among Westlake Chemical OpCo LP, Westlake Chemical Corporation, the other Subsidiary Guarantors (as defined therein) and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated by reference to Westlake Chemical Corporation's Quarterly Report on Form 10-Q, filed on August 6, 2014, File No. 001-32260).
|
4.13
|
|
Eighth Supplemental Indenture (including the form of the Notes), dated as of August 10, 2016, among Westlake Chemical Corporation, the Guarantors (as defined therein) and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated by reference to Exhibit 4.2 to Westlake Chemical Corporation's Current Report on Form 8-K, filed on August 10, 2016, File No. 001-32260).
|
|
|
|
4.14
|
|
Ninth Supplemental Indenture (including the form of the Notes), dated as of September 7, 2016, among Westlake Chemical Corporation, the Guarantors (as defined therein) and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated by reference to Exhibit 4.2 to Westlake Chemical Corporation's Current Report on Form 8-K, filed on September 7, 2016, File No. 001-32260).
|
|
|
|
4.15
|
|
Indenture dated as of September 8, 2016, among Westlake and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated by reference to Exhibit 4.4 to Westlake Chemical Corporation's Current Report on Form S-3, filed on September 8, 2016, File No. 333-213548).
|
|
|
|
4.16
|
|
Supplemental Indenture, dated as of October 25, 2016, among the Company, the Guaranteeing Subsidiaries (as defined therein) and the other Subsidiary Guarantors (as defined therein) and the Bank of New York Mellon Trust Company, as trustee (incorporated by reference to Exhibit 4.18 to Westlake Chemical Corporation's Annual Report on Form 10-K for the year ended December 31, 2016, filed on February 22, 2017, File No. 001-32260).
|
|
|
|
10.1
|
|
Omnibus Agreement among Westlake Management Services, Inc., Westlake Vinyls Corporation, Westlake Chemical Partners GP LLC, Westlake Chemical Partners LP, WPT LLC, Westlake Petrochemicals LLC, Westlake Vinyls, Inc., Westlake Longview Corporation, Westlake Chemical OpCo GP LLC, Westlake Chemical OpCo LP, Westlake PVC Corporation, Westlake Styrene LLC and Westlake Polymers LLC (incorporated by reference to Exhibit 10.1 to Westlake Chemical Partners LP's Current Report on Form 8-K (File No. 001-36567) filed on August 8, 2014).
|
|
|
|
10.2
|
|
Services and Secondment Agreement by and among Westlake Chemical OpCo LP, Westlake Management Services, Inc., Westlake Vinyls, Inc., WPT LLC and Westlake Petrochemicals LLC (incorporated by reference to Exhibit 10.2 to Westlake Chemical Partners LP's Current Report on Form 8-K (File No. 001-36567) filed on August 8, 2014).
|
|
|
|
10.3
|
|
Feedstock Supply Agreement between Westlake Petrochemicals LLC and Westlake Chemical OpCo LP (incorporated by reference to Exhibit 10.3 to Westlake Chemical Partners LP's Current Report on Form 8-K (File No. 001-36567) filed on August 8, 2014).
|
|
|
|
10.4††
|
|
Ethylene Sales Agreement between Westlake Chemical OpCo LP, WPT LLC, Westlake Vinyls, Inc. and Westlake Petrochemicals LLC (incorporated by reference to Exhibit 10.4 to Westlake Chemical Partners LP's Current Report on Form 8-K (File No. 001-36567) filed on August 8, 2014).
|
|
|
|
10.5
|
|
Site Lease Agreement (Calvert City) between Westlake Vinyls, Inc. and Westlake Chemical OpCo LP (incorporated by reference to Exhibit 10.5 to Westlake Chemical Partners LP's Current Report on Form 8-K (File No. 001-36567) filed on August 8, 2014).
|
|
|
|
10.6
|
|
Site Lease Agreement (Lake Charles) between Westlake Petrochemical LLC and Westlake Chemical OpCo LP (incorporated by reference to Exhibit 10.6 to Westlake Chemical Partners LP's Current Report on Form 8-K (File No. 001-36567) filed on August 8, 2014).
|
|
|
|
10.7
|
|
Amended and Restated Limited Partnership Agreement of Westlake Chemical OpCo LP (incorporated by reference to Exhibit 10.7 to Westlake Chemical Partners LP's Current Report on Form 8-K (File No. 001-36567) filed on August 8, 2014).
|
|
|
|
10.8†
|
|
Westlake Chemical Partners LP Long-Term Incentive Plan (incorporated by reference to Exhibit 10.8 to Westlake Chemical Partners LP's Current Report on Form 8-K (File No. 001-36567) filed on August 8, 2014).
|
|
|
|
Exhibit No.
|
|
Description
|
10.9†
|
|
Form of Phantom Unit Agreement under the Westlake Chemical Partners LP Long-Term Incentive Plan (incorporated by reference to Exhibit 10.14 to Amendment 4 to Westlake Chemical Partner LP's Registration Statement on Form S-1 (File No. 333-195551) filed on July 15, 2014).
|
|
|
|
10.10†*
|
|
Form of Global Amendment to Phantom Unit Agreements under the Westlake Chemical Partners LP Long-Term Incentive Plan.
|
|
|
|
10.11†*
|
|
Form of Phantom Unit Agreement.
|
|
|
|
10.12
|
|
Intercompany Revolving Credit Agreement between Westlake Chemical OpCo LP and Westlake Development Corporation (incorporated by reference to Exhibit 10.9 to Westlake Chemical Partners LP's Current Report on Form 8-K (File No. 001-36567) filed on August 8, 2014).
|
|
|
|
10.13
|
|
Unsecured Promissory Note between WPT LLC and Westlake Development Corporation (incorporated by reference to Exhibit 10.8 to Westlake Chemical Partners LP's Registration Statement on Form S-1 (File No. 333-195551), filed on June 30, 2014).
|
|
|
|
10.14***
|
|
Unsecured Promissory Note between Westlake Vinyls, Inc. and Westlake Development Corporation.
|
|
|
|
10.15***
|
|
Unsecured Promissory Note between Westlake Petrochemicals LLC and Westlake Development Corporation.
|
|
|
|
10.16
|
|
Senior Unsecured Revolving Credit Agreement by and among Westlake Chemical Partners GP LLC and Westlake Chemical Finance Corporation, dated as of April 29, 2015 (incorporated by reference to Exhibit 10.1 to Westlake Chemical Partners LP's Current Report on Form 8-K, filed on April 30, 2015, File No. 001-36567).
|
|
|
|
10.17
|
|
Credit Agreement, dated as of August 10, 2016, by and between Bank of America, N.A. and Westlake International Holdings II C.V. (incorporated by reference to Exhibit 10.3 to Westlake Chemical Corporation's Quarterly Report on Form 10-Q for the quarter ended September 30, 2016, and filed on November 9, 2016, File No. 001-32260).
|
|
|
|
10.18
|
|
Credit Agreement, dated as of August 23, 2016, by and among Westlake Chemical Corporation, the other borrowers and guarantors referred to therein, the lenders from time to time party thereto, the issuing banks party thereto and JPMorgan Chase Bank, National Association, as Administrative Agent, relating to a $1 billion senior unsecured revolving credit facility (incorporated by reference to Exhibit 10.1 to Westlake Chemical Corporation's Current Report on Form 8-K, filed on August 24, 2016, File No. 001-32260).
|
|
|
|
10.19
|
|
First Amendment to Ethylene Sales Agreement (incorporated herein by reference to Exhibit 10.1 to Westlake Chemical Partners LP's Quarterly Report on Form 10-Q for the quarter ended June 30, 2016, filed on August 9, 2016, File No. 1-32260)
|
|
|
|
10.20*
|
|
Exchange Agreement, effective as of August 1, 2014, by and between WPT LLC and Westlake Chemical OpCo LP.
|
|
|
|
21.1*
|
|
List of Subsidiaries of Westlake Chemical Partners LP.
|
|
|
|
23.1*
|
|
Consent of PricewaterhouseCoopers LLP.
|
|
|
|
31.1*
|
|
Rule 13a - 14(a) / 15d - 14(a) Certification (Principal Executive Officer).
|
|
|
|
31.2*
|
|
Rule 13a - 14(a) / 15d - 14(a) Certification (Principal Financial Officer).
|
|
|
|
32.1**
|
|
Section 1350 Certification (Principal Executive Officer and Principal Financial Officer).
|
|
|
|
101.INS*
|
|
XBRL Instance Document.
|
|
|
|
101.SCH*
|
|
XBRL Taxonomy Extension Schema Document.
|
|
|
|
101.CAL*
|
|
XBRL Taxonomy Extension Calculation Linkbase Document.
|
|
|
|
101.DEF*
|
|
XBRL Taxonomy Extension Definition Linkbase Document.
|
|
|
|
101.LAB*
|
|
XBRL Taxonomy Extension Label Linkbase Document.
|
|
|
|
101.PRE*
|
|
XBRL Taxonomy Extension Presentation Linkbase Document.
|
*
|
Filed herewith.
|
**
|
Furnished herewith.
|
***
|
The Unsecured Promissory Notes between Westlake Development Corporation and each of Westlake Vinyls, Inc. and Westlake Petrochemicals LLC are not filed because they are identical to Exhibit 10.12 except for the identity of the borrower.
|
†
|
Management contract or compensatory plan or arrangement.
|
††
|
Confidential status has been granted for certain portions thereof pursuant to the Order Granting Confidential Treatment Under the Securities Act of 1933 issued by the Division of Corporation Finance of the Securities and Exchange Commission filed on August 1, 2014.
|
Director’s
Full Name:
|
|
|
|
|
|
Last
|
|
First
|
|
Middle Initial
|
Signature
|
Date
|
Exchange Period/Term:
|
August 1, 2014 through August 1, 2015 and continuing year to year thereafter, unless otherwise terminated by either Party by giving written notice of termination to the other Party at least three (3) months in advance of the date of termination specified in such notice (“Term”).
|
Delivery Point(s)
|
Product
|
Quantity
|
|
Differential Fees Payable by Counterparty
|
Williams Storage Hub in Mt Belvieu TX
Or other mutually agreeable locations from time to time
|
Ethylene
(meeting specifications of Delivery Points)
|
Ratably, Up to 200 MM lbs. per year, or mutually agreeable
|
|
0.6 cents per pound, to be revised annually upon mutual consent by the Parties; provided that the Differential Fees shall never be lower than 0.6 cents per pound.
|
Delivery Point(s)
|
Product
|
Quantity
|
|
Differential Fees Payable by Westlake
|
The applicable Delivery Points as set forth in that certain ethylene sales agreement among Westlake, Counterparty and several other affiliates of Westlake (the “Ethylene Sales Agreement”)
Or other mutually agreeable locations from time to time
|
Ethylene
(meeting specifications in the Ethylene Sales Agreement)
|
Ratably, Up to 200 MM lbs. per year, or mutually agreeable
|
|
none
|
Special Provisions:
|
(1) Not less than five (5) days prior to the beginning of each month, Counterparty shall nominate Westlake of the quantity of Product to be exchanged that Westlake shall deliver during such month to Counterparty at the applicable Delivery Point(s). Westlake shall accept all such nominations pursuant to the terms and conditions of this Agreement.
|
Other Terms and Conditions:
|
Additional terms and conditions will apply per attached
General Terms and Conditions
as well as Confirms for each exchange, incorporated by reference for all purposes.
|
Name of Subsidiary
|
|
Jurisdiction
|
|
|
|
Westlake Chemical OpCo GP LLC
|
|
Delaware
|
|
|
|
Westlake Chemical OpCo LP
|
|
Delaware
|
1.
|
I have reviewed this Annual Report on Form 10-K of Westlake Chemical Partners LP (the "registrant");
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
a.
|
designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
b.
|
designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
c.
|
evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
d.
|
disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
|
5.
|
The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
|
a.
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
|
b.
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
|
Date:
|
March 7, 2017
|
|
/s/ A
LBERT
C
HAO
|
|
|
|
Albert Chao
President, Chief Executive Officer and Director of
Westlake Chemical Partners GP LLC
(Principal Executive Officer)
|
1.
|
I have reviewed this Annual Report on Form 10-K of Westlake Chemical Partners LP
(the "registrant");
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15(d)-15(f)) for the registrant and have:
|
a.
|
designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
b.
|
designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
c.
|
evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
d.
|
disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
|
5.
|
The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
|
a.
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
|
b.
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
|
Date:
|
March 7, 2017
|
|
/s/ M. S
TEVEN
B
ENDER
|
|
|
|
M. Steven Bender
Senior Vice President, Chief Financial Officer
Treasurer and Director of
Westlake Chemical Partners GP LLC
(Principal Financial Officer)
|
(1)
|
the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
|
(2)
|
the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Partnership.
|
Date:
|
March 7, 2017
|
|
/s/ A
LBERT
C
HAO
|
|
|
|
Albert Chao
President, Chief Executive Officer and Director of
Westlake Chemical Partners GP LLC
(Principal Executive Officer)
|
|
|
|
|
Date:
|
March 7, 2017
|
|
/s/ M. S
TEVEN
B
ENDER
|
|
|
|
M. Steven Bender
Senior Vice President, Chief Financial Officer,
Treasurer and Director of
Westlake Chemical Partners GP LLC
(Principal Financial Officer)
|